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Mucus is one important component of the intestinal mucosal barrier, and loss of 
its functionality is associated with colitis in humans and mice.  Mice deficient in core 1 
O-glycans (TM-IEC C1galt1-/-) display a thinner mucus layer upon mutation of the 
glycosyltransferase enzyme (C1GALT1) responsible for core 1 O-glycans attachment, 
thus constituting an experimental model for human Ulcerative Colitis (UC). Under 
conventional conditions, these mice experience spontaneous inflammation of the colon.  
However, the exact role of the microbiota in colitis development in these mice has not 
been systematically investigated.    
Aimed to gain insights into the role of the microbiota in colitis when there is a 
breach in the mucus barrier, we characterized the gut microbiota of conventional TM-IEC 
C1galt1-/- mice, tested the requirement of bacteria for initiation of colitis, and identified 
bacterial species associated with disease in this mice model.   
Analysis of fecal bacterial populations by pyrosequencing of 16S rRNA tags 
showed that disease in conventional TM-IEC C1galt1-/- was associated with microbial 
dysbiosis manifested by increases in Lactobacillus and Clostridium species, and 
decreases in unclassified Ruminococcus and unclassified Lachnospiraceae.  Under germ-
free (GF) conditions, deletion of the C1GALT1 enzyme caused decreased goblet cells, 
but did not result in inflammation, showing that bacteria are required for disease 
	   	   	  
development. Monoassociation of GF TM-IEC C1galt1-/- revealed that the selected 
bacterial species differ significantly in the ability to induce disease.  Bacteroides 
thetaiotaomicron and Bacteroides vulgatus showed association with induction of 
inflammation in this mice model. Bacteroides sartorii, Clostridium symbiosum, 
Akkermansia muciniphila, and Lactobacillus johnsonii not only did not cause 
manifestations of disease, but they induced high levels of secretory-IgA. 
Findings suggest that the relationship between the commensal microbiota and the 
intestinal epithelium skews towards development of inflammation in the presence of a 
defective mucus layer, but not all dysbiotic shifts contribute to disease.  Bacteroides 
species, which were not enriched in conventional TM-IEC C1galt1-/- mice, caused 
inflammation, while Lactobacillus johnsonii (enriched during colitis) did not.  This thesis 
represents the first reported evidence of microbial dysbiosis caused by lack of core 1 O-
glycans, and forms the basis for future work aimed to indentify bacterial factors related to 
disease. 
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Chapter 1 
Microbial changes and Epithelial Barrier 
in Inflammatory Bowel Diseases:  
A Review 
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1.1 IBD pathogenesis 
Inflammatory Bowel Diseases (IBD) are a group of intestinal inflammatory 
disorders, including Ulcerative Colitis (UC) and Crohn’s Disease (CD), that are 
considered multifactorial, involving atypical interactions between colonic bacteria, 
mucosal immune cells, and the intestinal epithelial barrier in genetically susceptible hosts 
(Sartor, 2006; Sartor and Muehlbauaer, 2007; Xavier and Podolsky, 2007; Strober et al, 
2007; McGukin et al, 2009).  Animal models and studies in patients with IBD implicate 
the intestinal microbiota in the initiation and perpetuation of inflammatory processes in 
the disease (Sartor and Muehlbauaer, 2007; Xavier and Podolsky, 2007).  
Several general hypotheses exist regarding the etiology of IBD.  One states that a 
dysregulation of the mucosal immune system, in the form of faulty mucosal effector T 
cells or regulatory T cells, leads to an aberrant immune response against the normal 
microbiota (Sartor, 2006; Sartor and Muehlbauaer, 2007; Strober et al, 2007).  A second 
hypothesis proposes that alterations in the constitution of the gut microbiota - either in the 
type of microorganisms that compose the population, or in the degree to which certain 
microorganisms challenge the mucosal immune barrier - trigger an immune response 
against the microbiota.  (Chichlowski and Hale, 2008; Sartor, 2006; Sartor and 
Muehlbauaer, 2007; Strober et al, 2007).  The third hypothesis, which has been addressed 
in this work, suggests that disturbances in the epithelial barrier, which includes the mucus 
layer, may result in increased interactions between the microbiota and the immune 
system, thus increasing susceptibility to the disease (Einerhand et al, 2002; McGuckin et 
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al, 2009; Fu et al, 2011).  All these scenarios converge on a possible relationship between 
the gut microbiota and the development of inflammation.    
Evidence of the role of bacteria in precipitating the disease is seen in the positive 
effects of antibiotics in amelioration of symptoms (Reviewed by Sartor, 2004); the 
association between pathways for recognition of microbial molecular patterns and antigen 
presentation in disease development (i.e. mutations in nucleotide-binding oligomeraizing 
domains (Nod) and Toll-like receptors (TLRs)) (Cho, 2008); and the experimental 
requirement for bacteria in most animal models of IBD to initiate inflammation (Sadlack 
et al, 1993; Elson et al, 1995).  Despite this evidence, there is no convincing proof of a 
single bacterial species associated with the development of IBD.  An imbalance between 
protective and harmful bacteria results from the breakdown in host-microbial mutualism 
interactions (Backhed et al, 2005) contributing to development of disease. 
 
1.2 The intestinal mucosal barrier and its relation to IBD 
The intestinal mucosal barrier constitutes one of the largest surface areas that is 
exposed to, and continually interacts with, the external environment.  It has developed to 
maintain a sensitive balance between absorbing essential nutrients and protecting from 
harmful matter, and it is a vital site for innate and adaptive immune regulation.  Antigens 
are being sampled by M cells (also known as microfold or membranous cells), dendritic 
cells and macrophages constantly across the epithelial layer, at the boundary between the 
mucosal immune system and the external luminal contents.  The excessive uptake of 
antigens may elicit an exaggerated immune response leading to inflammation.   The 
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capacity to manage antigen uptake is denoted as the intestinal barrier function (Salim and 
Soderholm, 2011).   
The intestinal epithelial monolayer is a physical barrier between the internal and 
external environment.  Additionally, the mucus layer, the luminal commensal microbiota, 
and the inner subepithelial cells and their products (i.e. dendritic cells, macrophages, and 
lymphocytes that produce cytokines and chemokines and form part of the innate and 
adaptive immune system) shape the intestinal barrier.   Schematics of a normal and a 
disrupted intestinal mucus barrier are presented in Figures 1.1 and 1.2, respectively. 
 
1.2.1 Intestinal Epithelial Cells 
The epithelial monolayer is composed of a series of cells organized in a single 
thoroughly folded layer to produce crypts and villous protrusions.  It is composed of four 
cell lineages that arise from a single epithelial stem cell (Barker et al, 2008), and that are 
interconnected through tight junctions (TJs) that regulate the barrier permeability.  These 
cells include goblet cells, enterocytes, enteroendocrine cells, and Paneth cells, each one 
with a specific function (Salim and Soderholm, 2011; Henderson et al, 2011).  
Enterocytes are mainly absorptive cells that regulate nutrient and ion absorption through 
microvillar extensions and their receptors, essential for dietary antigen uptake.  The main 
role of goblet cells is mucus production, while enteroendocrine cells produce hormones 
and neuropeptides, and Paneth cells primarily produce antimicrobial factors 
(Ramasundara et al, 2009).  Both, Paneth cells and enterocytes have a direct influence in  
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Figure 1.1 Normal O-glycosylation of the mucus layer ensures a normal 
intestinal barrier function by preventing aberrant interactions between 
commensal bacteria, epithelial cells and the mucosal immune cells. 
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Figure 1.2 Lack or core 1 O-glycans in the mucus layer results in an impaired 
mucus barrier allowing closer interactions between the commensal microbiota 
and the epithelial layer, thus inducing an immune response towards the host’s 
microbiota.   
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the normal commensal microbiota and invading pathogens.  While Paneth cells produce a 
diversity of defensins, lectins and related antimicrobial substances, enterocytes play a 
role in the transcytosis of secretory immunoglobulin A (sIgA) into the intestinal lumen 
(Kaetzel, 2005) by putting accross a polymeric receptor that binds to the dimeric form of 
IgA, thus completing the formation of sIgA.  
Besides forming a physical barrier, epithelial cells are equipped with pattern 
recognition receptors (PRRs), such as TLRs, and NOD-like receptors (NLRs) that are 
essential for the identification and response to microbial components (Reviewed by 
Kawai and Akira, 2009).   Upon recognition of microbial-associated molecular patterns 
(MAMPs) by the PRRs, a cascade of signals is evoked either towards tolerance of 
resident beneficial bacteria, or for the eradication of pathogenic microbes.  An abnormal 
signaling through PRRs could evoke inflammatory responses leading to chronic 
inflammation.  Moreover, mutations in genes related to pathways for recognition of 
MAMPs and antigen presentation (i.e. NOD2, CARD15, ATG16L1) have been associated 
to predisposition to inflammatory processes and IBD (Henckaerts et al, 2007; Frank et al, 
2011). 
In addition, the TJs that connect the individual epithelial cells assist in the 
epithelium’s general function as a barrier.  The proteins that form the TJs aid in 
maintaining cellular polarity and are directly involved in epithelial cell differentiation 
(Schulzke et al, 2008; Hossain and Hirata, 2008).  They regulate transport of water, 
electrolytes, and nutrients across the epithelium.  Defects in permeability associated to 
faulty TJs have been reported in IBD patients (Secondulfo et al, 2001; Clayburgh et al, 
2004). 
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1.2.2 Mucus Layer 
Goblet cells secrete large quantities of mucin glycoproteins and other mucus 
components (trefoil peptides, Fcγ binding protein, and resistin-like molecule β) that come 
together to build a protective gel-like coat, with varying degrees of viscosity and 
thickness, which overlies the gastrointestinal tract (GIT) (Rubinstein and Tirosh, 1994; 
Atuma et al, 2001; Holm and Phillipson, 2012; Varum et al, 2012).  The proportion of 
goblet cells was found decreased in both, UC and CD, being specifically diminished in 
the upper third of the crypts in UC (Gersemann et al, 2009).  A low number of goblets 
cells directly affect the mucus gradient and its function as a barrier. The thickness 
gradient influences bacterial colonization and establishment of microbial niches (Jager et 
al, 2013), and it has been shown to be altered in active IBD (Pullan et al, 1994; Strugala 
et al, 2008).  The vast majority of bacteria in the lumen concentrate in the outer layer of 
the mucus; while an inner layer, devoid of bacteria, neighbors the epithelial cells 
(Johansson et al, 2008).  The sterility of the inner layer is due in part to the high 
concentration of antimicrobial peptides that localizes in the mucosal surfaces (Meyer-
Hoffert et al, 2008).   
The expression of mucin glycoprotein in the gut is mainly directed by the MUC2 
gene.  The vital role of the mucus layer in maintaining the intestinal mucosal physical 
barrier was demonstrated in MUC2 knockout mice that spontaneously developed colitis 
due to bacterial closeness to epithelial cells (Van der Sluis et al, 2006).  Furthermore, 
aberrant expression of mucin genes and defective post-transcriptional processing of MUC 
2 mucins have been found in human IBD (Moehle et al, 2006).   
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Additionally, deficiency of carbohydrate moieties attached to mucin backbones, 
including core 1, core 2, and core 3 O-glycans, have been linked to predisposition and 
development of inflammation; and, in some cases, to colorectal cancer (An et al, 2007; 
Stone et al, 2009; Fu et al, 2011).   O-glycans are synthesized in the Golgi apparatus 
starting at the Tn antigen, N-Acetylgalactosamine (GalNAc) attached through an O-link 
to serine and threonine residues in the mucin backbone (Xia et al, 2004) (Figure 1.3).  
The Tn antigen is normally covered by other O-glycans that are synthesized by the action 
of several kinds of glycosyltransferases.  The core 1 synthase, glycoprotein-N-
acetylgalactosamine 3-β-galactosyltransferase 1 (C1GALT1, also known as T-synthase) 
specifically synthesizes core 1 O-glycans.  Patients with UC were found to express the Tn 
antigen, and a subset of them presented mutations in the gene that encodes core 1 β1,3-
galactosyltransferase-specific chaperone protein 1 (C1GALT1C1, also known as Cosmc) 
(Fu et al, 2011) which is essential for the action of C1GALT1 (Ju and Cummings, 2002; 
Aryal et al, 2010), thus limiting core 1 O-glycans synthesis.   
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1.2.3 Subepithelial Immune Cells 
Peyer’s patches are formed by aggregated lymphoid follicles with specialized 
epithelium called the follicular-associated epithelium (FAE).  Within the FAE, 
specialized M cells continuously sample lumen contents by endocytosis, delivering the 
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Figure 1.3 Synthesis of core 1 O-glycans starts at the Tn antigen by the action of the 
C1GALT1 enzyme, which in turn depends of the Cosmc chaperone protein.  Other 
glycosyltransferases, specific for the added carbohydrates moieties, mediate core 1 O-glycans 
chain elongation.  Mutations in Cosmc have been found in UC patients, thus having defective 
core 1 O-glycans synthesis.  Tn antigen, C1GALT1 enzyme and Cosmc chaperone protein are 
circled in red. 
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sampled material to immune cells located in the subepithelial dome of the lymphoid 
follicle (Corr et al, 2008). Subsequently, the lumen content is collected by antigen 
presenting cells (APCs) and by lymphocytes (Neutra et al, 2001) that either ignore or 
respond to foreign antigens.  The actions of the APCs could elicit a series of effects that 
might include T-cell-independent IgA production, and T-regulatory responses, among 
others (Macpherson and Uhr, 2004, Fleeton et al, 2004).  After stimulation, the 
lymphocytes will release cytokines and chemokines capable of influencing the epithelial 
integrity, thus preventing or predisposing to inflammation (Suenaert et al, 2010).  For 
example, Enss et al (2000) found that mucin expression and structure is influenced by 
proinflammatory cytokines in an intestinal cancer cell line. 
 
1.2.4 Commensal Microbiota 
 The commensal microbiota plays several roles that are critical to the host’s health.  
Besides contributing to nutrient acquisition (Backhed et al, 2004), the microbiota aids in 
limiting colonization by pathogens (Artis, 2008), and in promoting the development and 
maturation of the immune system (Umesaki and Setoyama, 2000; Round and 
Mazmanian, 2009).  The general scenarios leading toward development of IBD include a 
role for the host microbiota (addressed in section 1.1).  Changes in the microbiota 
identified in IBD disorders are discussed in section 1.3 and summarized in Table 1.1. 
  
 
 
	   12	  
1.3  Microbial characterization in IBD  
The majority of the known symbionts of the GIT establish mutualistic 
relationships with the host.  Commensal microorganisms benefit from a steady supply of 
nutrients and a relatively stable environment, while the host receives nutritional and 
digestive benefits, protection against colonization by pathogens, and stimulation of the 
immune system for its development and maturation (Umesaki and Setoyama, 2000; 
Round and Mazmanian, 2009).  Alterations in the environment and the microbiota’s 
composition might result in the acquisition of virulence factors by some commensals, 
turning them into pathogens and predisposing to disease. 
In general, molecular analyses of the gut microbiota in IBD have found a 
reduction in diversity of the microbial communities in the disease, characterized by a 
decrease in the population of Firmicutes (Frank et al, 2007; Willing et al, 2010; Walker et 
al, 2011).  However, research on microbial changes for other phyla is still inconclusive 
with regards to which bacterial taxa are linked to inflammation.  For instance, while some 
researchers found increased Clostridial population in the disease (Mylonaki et al, 2005), 
suggesting a causal role for the organism, further investigations have found that this 
group is depleted in the disorder (Gophna et al, 2006; Andoh et al, 2011).  In fact, a 
decrease in Faecalebacterium prausnitzii in CD is the only element found in agreement 
between several groups or researchers (Sokol et al, 2009; Willing et al, 2010; Joossens et 
al, 2011; Morgan et al, 2012; Kabeerdoss et al, 2013).  F. prausnitzii belongs to the order 
of the Clostridiales and has been associated with anti-inflammatory properties.  
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Similar issues rise for Bacteroides species.  Swidsinski et al (2005) found 
Bacteroides species as the predominant group in inflamed colon, while other studies 
found no changes (Mylonaki et al, 2005), or even a decrease in population size of 
Bacteroides in active state of the disease (Frank el al, 2007; Noor et al, 2010).   
Results that suggest a relationship for particular Bacteroides species with the 
disease, either as causative or preventive of inflammation, are uncertain and sometimes 
conflicting for both, animal models and IBD patients.  For example, high levels of 
antibody against the outer membrane of B. vulgatus were found in UC patients suggesting 
a role for the bacterium in the pathogenesis of the disease (Bamba et al, 1995).  In the 
case of B. ovatus, elevated IgG and IgA titers against this species were found in patients 
with CD and UC, suggesting a role of the organism in the immune response to the disease 
(Saitoh et al, 2002).  Conversely, in animal models, it was found that B. vulgatus plays a 
role against the development of colitis in IL-10 KO mice (Sydora et al, 2005).  On the 
other hand, Hudcovic et al, (2009) found that B. ovatus protects immunodeficient SCID 
mice from further inflammation in dextran sodium sulfate (DSS)-induced injury of the 
colon.   This paradox warrants further research in order to determine a causal relationship 
between specific bacterial species and development of inflammation.  Table 1.1 
summarizes major changes in microbial communities found in human IBD. 
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Table 1.1 Dysbiosis in the gut microbiota in human IBD 
Subjects	   Methods	   Main	  Findings	   References	  33	  UC	  patients	  6	  CD	  patients	  14	  controls	  	   FISH	   ↓	  Bifidobacteria	  in	  UC	  ↑	  E.	  coli	  in	  active	  UC	  and	  CD	  relative	  to	  controls	  ↑	  Clostridia	  in	  active	  UC	  
=	  Lactobacillus	  &	  Bacteroides	  
Milonaki	  et	  al,	  2005	  
13	  CD	  patients	  13	  UC	  patients	  5	  IC	  patients	  13	  controls	  (HS)	  
FISH	  Facs	   ↓	  Diversity	  in	  IBD	  relative	  to	  HS	  &	  IC	  	  ↓	  Firmicutes	  in	  IBD	  
↓	  Clostridium	  coccoides	  group	  in	  UC	  
↓	  Clostridium	  leptum	  group	  in	  CD	  
↑	  Bacteroides	  in	  IC	  
=	  Enterobacteria,	  Atopobioum	  	  	  	  &	  Bifidobacterium	  between	  phenotypes	  
Sokol	  et	  al,	  2006	  
6	  CD	  patients	  5	  UC	  patients	  5	  controls	  (HS)	   High-­‐throughput	  sequencing	   ↑	  Proteobacteria	  in	  CD	  relative	  to	  UC	  &	  HS–	  mainly	  γ	  Proteobacteria	  and	  E.	  coli	  ↑	  Bacteroidetes	  in	  CD	  –	  mainly	  B.	  vulgatus	  	  
↓	  Clostridia	  in	  CD	  UC	  tissue-­‐associated	  flora	  broadly	  =	  to	  HS	  	  
Gophna	  et	  al,	  2006	  
68	  CD	  	  61	  UC	  61	  controls	  	  (non-­‐IBD)	  
	  
Molecular-­‐phylogenetic	  sequence	  analysis	  Q-­‐PCR	  
↑	  Actinobacteria	  in	  IBD	  
↑	  Proteobacteria	  in	  IBD	  
↓	  Bacteroidetes	  in	  IBD	  
↓Lachnospiraceae	  in	  IBD	  	  
Frank	  et	  al,	  2007	  
32	  CD	  patients	  17	  UC	  patients	  8	  IC	  patients	  27	  controls	  (HS)	  
	  
QRT-­‐PCR	   ↓	  C.	  leptum	  &	  C.	  coccoides	  in	  IBD	  &	  IC	  
↓	  F.	  prausnitzii	  in	  IBD	  &	  IC	  
↓	  Bifidobacteria	  in	  IBD	  &	  IC	   Sokol	  et	  al,	  2009	  
15	  twin	  pairs	  UC	  23	  twin	  pairs	  CD	  2	  twin	  pairs	  controls	  (HS)	  
454	  FLX	  sequencing	   UC	  microbiota	  broadly	  =	  to	  HS	  
↑	  Ruminococcaceae	  in	  CD	  
↑	  Lactobacillaceae	  in	  ICD	  
↑	  Faecalebacterium	  in	  CD	  but	  ↓	  in	  ICD	  
↓	  Streptococcus	  in	  UC	  
↓	  Prevotella	  in	  UC	  
↑	  Enterobacteriaceae	  in	  ICD	  
Willing	  et	  al,	  2010	  
13	  UC	  patients	  22	  controls	  (HS)	   PCR-­‐DGGE	   ↓	  Diversity	  in	  UC	  relative	  to	  HS	  ↓	  Bacteroides	  in	  UC	  mainly	  B.	  vulgatus,	  B.	  ovatus,	  
B.	  uniformis	  &	  Parabacteroides	  spp.	  	  
Noor	  et	  al,	  2010	  
6	  CD	  patients	  6	  UC	  patients	  5	  controls	  (HS)	   High-­‐throughput	  sequencing	  	  Q-­‐PCR	   ↓	  Diversity	  in	  CD	  than	  UC	  	  ↓	  Firmicutes	  in	  IBD	  ↑	  Bacteroidetes	  in	  IBD	  
↑	  Enterobacteria	  in	  CD	  	  
Walker	  et	  al,	  2011	  
31	  UC	  patients	  31	  CD	  patients	  30	  controls	  (HS)	   T-­‐RFLP	  analysis	   ↓	  Clostridium	  in	  CD	  &	  UC	  ↑	  Bacteroides	  in	  CD	   Andoh	  et	  al,	  2011	  68	  CD	  patients	  84	  non	  CD	  relatives	  55	  controls	  
DGGE	   ↓	  Faecalebacterium	  prausnitzii	  	  
↓	  Bacteroides	  adolescentis	  
↓	  Dialister	  invisus	  
↑	  Ruminoccocus	  gnavus	  	  
Joossens	  et	  al,	  2011	  
6	  active	  UC	  pts	  6	  remission	  UC	  	  6	  controls	  (HS)	   DGGE	  Q-­‐PCR	   ↓	  Lactobacillus	  spp.	  in	  active	  UC	  ↓	  Akkermansia	  muciniphila	  in	  active	  UC	  	   Vigsnaes	  et	  al,	  2012	  121	  CD	  patients	  75	  UC	  patients	  27	  controls	  (HS)	   454	  FLX	  sequencing	   ↓	  Roseburia	  in	  IBD	  ↓	  Ruminococcaceae	  &	  F.	  prausnitzii	  	  in	  CD	  ↑	  Escherichia/Shigella	   Morgan	  et	  al,	  2012	  
CD: Crohns disease, UC: Ulcerative Colitis, ICD: CD localized in the ileum, IC: Infectious colitis, HS: Healthy subjects, ↑:	  increase,	  ↓:	  decrease,	  =:	  similar	  to	  control 
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1.4  Bacterial capacity for colonization and carbohydrates 
utilization 
 Being sterile at birth, the gastrointestinal tract of the human neonate is rapidly 
colonized by microbes upon exposure to the environment, parental contact, and diet 
antigens (Palmer et al, 2007).  Many factors affect the initial composition of the neonate’s 
microbiota, including mode of delivery (vaginal or cesarean), enteric feeding (breast-fed 
or formula), and gestational age at birth (Penders et al, 2006; Biasucci et al, 2010), 
among others.  The composition of the neonate microbiota varies greatly between 
individuals (Palmer et al, 2007).  Initially governed by Bifidobacteria (Stark and Lee, 
1982), the breast-fed infant gut microbiota is rapidly affected by further exposure to 
environmental and food antigens, being eventually transformed into an “adult” 
microbiota that harbors up to 100 trillion (1014) microbes, dominated by Firmicutes and 
Bacteroidetes (Eckburg et al, 2005).  What makes the microbiota such as dynamic entity? 
Throughout the host life, the microbiota is persistently challenged by several 
physical, chemical and metabolic factors, inherent to the host, which may affect its 
composition (Booijink et al, 2007).  Continuous epithelial cell and mucus turnover (Kim 
et al, 2010), immune defense mechanisms (Sansonetti and Medzhitov, 2009), peristalstic 
movements, pH gradients, and host’s digestive enzymes (Booijink et al, 2007) are some 
of the elements that microbes defy for niche establishment and survival.  In addition, the 
members of the microbiota are subjects of competitive exclusion, and they are affected by 
antibiotic usage during disease stages of the host.  
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The composition of the microbiota varies along and across the GIT (Swidinski et 
al, 2007; reviewed by Walter and Ley, 2011), with some species attached to the 
epithelium and others found in the lumen.  Niche establishment within the gut requires 
that commensals evolve to develop strategies to avoid immune recognition by actively 
repressing or modulating the host response (Sansonetti and Medzhitov, 2009).  
Additionally, they need the capacity to utilize available nutrients within their surrounding 
environment.  These nutrients include host’s diet complex carbohydrates, as well as 
host’s mucosa-associated glycans.   
The ability of the microbiota to metabolize complex carbohydrates is granted by 
an abundant repertoire of degrading enzymes that are selectively expressed depending on 
environmental pressures (Martens et al, 2011).   However, not all members of the gut 
microbiota have a vast enzymatic potential.  Some have limited degrading capability, 
while others depend on metabolic products of neighboring microbes for their survival 
(Xu et al, 2007; Png et al, 2010).  
As an example of metabolic attributes, the human symbiont Bacteroides 
thetaiotaomicron is able to express 209 paralogs of SusC and SusD (proteins related to 
starch and maltooligosaccharide utilization), 226 glycoside hydrolases, and 15 
polysaccharide lyases, that are able to breakdown any type of diet or host glycans within 
the gut (Cho and Salyers, 2001; Sonnenburg et al, 2005; Xu et al, 2007).  In contrast, 
another member of the Bacteroidetes, Parabacteroides distasonis, has only one candidate 
α-fucosidase, two classes of carbohydrate-processing enzymes, and 7 polysaccharide 
deacetylases, thus limiting the metabolic capacity for the utilization of carbohydrate 
sources (Xu et al, 2007).  Still, P. distasonis posses a greater faculty for protein 
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degradation than B. thetaiotaomicron does (Xu et al, 2007).  The increased ability of B. 
thetaiotaomicron to exploit surrounding nutrients confers the bacterium fitness 
advantages and categorizes it as a “generalist”.  P. distasonis is classified as a 
“specialist”, being able to merely metabolize specific diet components (Xu et al, 2007).  
These metabolic characteristics have an immense influence in niche selection and 
establishment, since the bacterium ability to express gene clusters for nutrient utilization 
will decide its fate, endurance and persistence along the GIT. 
 
1.5 Humoral Immune response in IBD 
 One of the major challenges that microorganisms confront in their endeavor to 
colonize the host is evasion of the immune system.  Humoral immunity is the part of the 
immune system mediated by macromolecules found in extracellular fluids.  It comprises 
secreted antibodies, specific antimicrobial peptides, and complement proteins, among 
other elements.  Secreted antibodies perform immune exclusion as a first-line of defense, 
thus counteracting bacterial colonization and penetration of soluble antigens into the 
mucosa.  This section briefly summarizes general findings in immunoglobulin (Ig) levels 
associated with human IBD.  
Contrary to normal healthy mucosa, the mucosa of both, UC and CD patients, 
contains large amounts of IgG relative to healthy subjects, the levels being higher in UC 
than CD (Gouni-Berthold et al, 1999; Furrie et al, 2003).  The IgG isotype associated 
with UC is IgG1 in serum and mucosal cells, while the one associated with CD is IgG2 
(Kett et al, 1987; Ruthlein et al, 1992; Philipsen et al, 1995; Furrie et al, 2003), 
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suggesting differences in the immune mechanisms involved in these diseases.   Other 
studies have found increases in both IgG1 and IgG3 in UC (Dorn et al, 2002).  It is still 
uncertain whether the high IgG response in IBD patients originates in the periphery (not 
localized in the mucosa), or in the mucosa.  However, studies do suggest that the 
response is originated peripherally, and IgG is transported across the enterocyte into the 
mucosa (Thoree et al, 2002; Hansen et al, 2006).  Despite the differences in IgG levels 
and isotypes between the phenotypes, some researchers consider that the levels of this 
antibody do not constitute a reliable marker to distinguish between UC and CD since not 
in all patients the changes correlate positively with disease activity (Gouni-Berthold et al, 
1999). 
Conversely, decreased levels of mucosal IgA in IBD were found relative to 
controls in both, UC and CD (Philipsen et al, 1995; Brandtzaeg et al, 2006).  
Interestingly, mononuclear cells (MNC) from patients with CD exhibit primarily dimeric 
IgA and relatively small amounts of monomeric IgA, while the opposite is observed in 
UC (MacDermott et al, 1983).  Since in normal mucosa the majority of the IgA is 
dimeric, the presence of monomeric IgA in the intestine could be due to homing of 
monomeric IgA-producing cells into the intestine, or to in situ proliferation due to 
immune alterations.  However, in contrast to control MNCs, a higher percentage of the 
intestinal IgA subtype identified in IBD was IgA1 (MacDermott et al, 1986; Kett and 
Brandtzaeg, 1987), which is less resistant to proteolytic degradation (Brandtzaeg et al, 
2006).  Secretory IgA (sIgA) assists innate mechanisms in protecting the epithelium, thus 
strengthening its function as a barrier.  In the absence of sIgA, gut commensals could 
overstimulate the innate immune system predisposing to inflammation. 
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 Regarding IgM, the findings are conflicting.  While some studies have found no 
changes in the levels of serum IgM in either of the two IBD phenotypes (Philipsen et al, 
1995), other investigations have reported higher levels of lamina propria (LP) cells 
expressing IgM in CD relative to controls (Dorn et al, 2002).  However, differences 
might arise from the nature of the samples tested (serum versus Ig-expressing LP cells) 
and variations in the methods used for immunoglobulin measurement between the 
studies. 
 Studies have found that the Igs of IBD patients are directed towards cytoplasmic 
bacterial components, rather than membrane proteins (Macpherson et al, 1996).  
Additionally, IBD patients have a higher number of Ig-coated bacteria (IgG, IgA, and 
IgM) in feces than controls, implying loss of tolerance to the commensal microbiota (van 
der Waaij et al, 2004; Harmsen et al, 2012).  This supports the theory that the etiology of 
IBD is an aberrant immune response to the normal microbiota. 
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1.6 Specific Aims, Rationale and Significance 
Murine models resemble certain aspects of human diseases closely enough to 
constitute efficient tools for the investigation and elucidation of predisposing factors, as 
well as alternative treatments to human illnesses. The core 1 synthase, glycoprotein-N-
acetylgalactosamine 3-beta-galactosyltransferase 1 enzyme (also known as T-synthase, 
abbreviated C1GALT1), is the enzyme responsible for attachment of O-glycans in the 
mucin proteins that form the mucus layer.  The core 1 O-glycans deficient (C1galt1-/-) 
mice model resembles human UC by having an incomplete, thin mucus layer similar to 
that found in a subset of UC patients (Pullan et al, 1994; Strugala et al, 2008).  In this 
report, we described the gut microbiota of conventional C1galt1-/- mice using 16s rRNA 
sequencing, we determined if germ-free (GF) with a Tamoxifen-induced mutation 
specific to intestinal cells (TM-IEC) C1galt1-/- mice develop colitis, and we colonized GF 
TM-IEC C1galt1-/- mice with selected single bacterial species to determine their 
colitogenic potential in this mice model.  By characterizing the gut microbiota in the 
C1galt1-/- mice with a disrupted mucus layer, we elucidated: (A), the putative role of 
specific bacterial species in the disease; and (B), whether or not a breach in the mucus 
layer by itself predisposes to disease development in the absence of microbes.  The 
identification of specific bacterial species associated with disease development or 
prevention could be used in the development of appropriate antimicrobial treatments 
against the causative microorganism, while preserving beneficial commensals.  With this 
set of results, we can start to understand the species-specific or strain-specific character 
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of host-microbial interactions that promote colitis in the absence of normal mucus 
synthesis. 
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2.1 Introduction 
 Most gnotobiotic animal models of IBD require the presence of bacteria for the 
host to develop disease.  The aim of the experiment addressed in this chapter was to 
determine if core 1 O-glycans deficient mice (C1galt1-/-), which are known to 
spontaneously develop colitis in a conventional setting (Fu et al, 2011), would become 
diseased in a germ-free setting.  
Gnotobiology is defined as the study of organisms that are either germ-free (GF) - 
containing no bacteria, viruses, fungi or any other form of commensal or pathogenic 
symbiont - or that are associated with known, specific bacteria (Coates, 1975).  The 
development of gnotobiology has provided new approaches to elucidate the etiology of 
diseases, as well as the dynamics of microbe-host relationships and their influence in the 
development, establishment and maintenance of the immune system.  The 
gnotobiological approach confers the ability to control and manipulate the environment in 
which an organism develops and performs, and combined with genetic technologies, is 
instrumental in the elucidation of the crosstalk between symbiotic and pathogenic 
microorganisms and both, healthy and diseased hosts (Reviewed by Falk et al, 1998).  
Thompson and Trexler (1971) reviewed the differences in the gastrointestinal 
tract (GIT) structure and function between GF and conventionally raised animals.  
Murine models are the ones mostly studied by gnotobiology (as opposed to chicken, pig, 
dog or cattle models), and differences have been identified between GF mice and their 
conventional, age-matched, counterparts.  Morphological modifications in the GIT of GF 
mice include, but are not limited to, enlargement of the cecum (5 to 10 times larger than 
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normal), thinner intestinal wall, thinner mucus layer, longer villi in the small intestine, 
and shorter crypts that contain fewer cells.  In addition, GF mice have slower intestinal 
motility (speed of transit and gastric emptying) than conventional mice.  These 
differences could be subsided by the introduction of bacteria in the gut, thus 
demonstrating a definite relationship between the microbiota and the morphology of the 
gut (Huseby et al, 1994).  
The absence of microbes in GF mice has a direct impact in their immune system, 
including a reduced number and size of Peyer’s patches (PP), decreased intestinal 
immunoglobulin (Ig) A-secreting plasma cells, reduced CD4+ T cells in the lamina 
propria (LP), and changes in T cell phenotype in the intraephitelial compartment 
(Macpherson and Harris, 2004; Macpherson et al, 2005).  Regarding Igs in serum, GF 
mice display normal levels of IgM, reduced levels of IgA and IgG, and increased levels 
of natural IgE relative to conventional mice (Macpherson and Harris, 2004; McCoy et al, 
2006).  Although the immune system of GF mice is capable of responding to antigens, 
stronger responses are achieved in conventionalized (ex-germ-free) mice and, even 
stronger, in conventional (with a normal microbiota since birth) mice (Fubara and Freter, 
1972). 
The requirement of bacteria to induce inflammation has been proved in several 
murine models of inflammatory disorders, such as the interleukin 2 deficient (IL-2-/-) 
mice, the interleukin 10 deficient (IL-10-/-) mice, T cell receptor αβ deficient (TCRα-/-) 
mice, and the HLA-B27/β2m transgenic rat (which express human MHC class I and 
human β2 microglobuline) (Dianda el al, 1997; Reviewed by Podolsky, 1997).  In these 
models, the host does not develop inflammation if kept germ-free.   
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The Core 1 synthase, C1GALT1, is the enzyme responsible for attachment of core 
1 O-glycans in the mucin proteins that form the mucus layer.  Conventional mice that 
lack the T-synthase enzyme (C1galt1-/-) spontaneously develop colitis (Fu et al, 2011).  
However is still unknown if the C1galt1-/- mice model in a GF setting will develop 
inflammation.  A Tamoxifen-induced mutation specific to the intestinal epithelia was 
generated in C1galt1-/-mice (TM-IEC C1galt1-/-) in a GF setting.  Mutation induction was 
performed in GF TM-IEC C1galt1-/- mice to determine whether a breach in the mucus 
barrier in the absence of microbes predisposes to inflammation. GF WT mice and 
conventionalized (ex-germ-free) core 1 O-glycans deficient mice were used as controls. 
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2.2  Materials and Methods 
2.2.1 TM-IEC C1galt1-/- Mice 
Breeding of C1galt1-/- mice with VillinCre-ERT2 transgenic mice, both on a 
C57BL/6J congenic background, generated Tamoxifen (TM)-inducible intestinal 
epithelial cell-specific C1galt1-/- mice (TM-IEC C1galt1-/-) who were made germ-free 
(GF) at Taconic Farms, Inc.  Mice were bred in the Gnotobiotic Mice Facility at the 
University of Nebraska-Lincoln, and weaned at four weeks of age.  Mice were genotyped 
by PCR assay on genomic DNA isolated from tail clippings.  The primers used include 
CRE1: 5’-AGGTGTAGAGAAGGCACTTAGC-3’, and CRE2: 5’-
CTAATCGCCATCTTCCAGCAGG-3’.  Six to ten mice, 6 to 7 weeks old were used per 
experiment including Cre-negative (WT), age-matched littermates as controls. Mice were 
colonized by orally gavaging 200µl of the total contents of cecums previously harvested 
from two conventional C57BL/6J mice and diluted in 4ml of sterile PBS.  Tamoxifen 
(TM; MP Biomedicals) was injected intraperitoneally (1mg in an ethanol/sunflower oil 
mixture 1:9 v/v) for 5 consecutive days in a blinded fashion to both, WT (Cre-) and TM 
IEC C1galt1-/- (Cre+) mice.  Therefore, a vehicle-control group - treated with 
ethanol/sunflower oil (without TM) - was not needed.  Both, WT and TM IEC C1galt1-/- 
started TM treatment 48 to 72 hours post-colonization.  TM treatment was completed 
before the mice were 8 weeks old.  Mice weights were monitored and recorded every 
other day, and they were sacrificed 20 days after TM injections.  Figure 2.1 shows a 
schematic representation of the experimental protocol. 
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2.2.2  Sample collection 
Cecum contents were snap-frozen in liquid nitrogen. The distal colon was divided 
into three sections and preserved in liquid nitrogen, Carnoy’s fixative (60% methanol, 
30% chloroform, 10% glacial acetic acid), and 10% formalin, respectively.  
 
 
Figure 2.1 Schematic representation of the experimental protocol.  [A] Generation of mice with an 
inducible deficiency of core 1 O-glycans specific to the intestinal epithelia (TM-IEC C1galt1-/-) was 
achieved by breeding C1galt1-/- mice with Villin-Cre-ERT2 transgenic mice.  They were made GF at 
Taconic Farms, Inc. [B] GF mice were colonized with 200µl of diluted cecal contents. Subsequently (48 to 
72 hours post-colonization), 1mg of Tamoxifen (TM) diluted in an ethanol and sunflower oil mixture (1:9 
v/v) was injected intraperitoneally for five consecutive days to both, WT and TM-IEC C1galt1-/- mice.  
Mice were sacrificed 20 days after TM treatment.   
 
 
2.2.3 Immunohistochemical and Immunofluorescence staining of 
the distal colon tissue 
2.2.3.1  Fluorescence in-situ hybridization (FISH)  
FISH was performed to assess bacterial colonization and mucosal association.  
Samples were embedded in paraffin after fixing them in 10% formalin or Carnoy’s 
fixative.  Once paraffin embedded, they were left to dry at room temperature (RT) 
X
C1galt1f/f-Villin-Cre-ERT2 
(TM-IEC C1galt1-/-) 
 C1galt1f/f              Villin-Cre-ERT2 
A          B 
  Day 1           3                     8                  15                  20               25              28 
Conventionalization 
by orogastric 
administration of 
cecal contents from 
conventional mice 
Sacrifice: 
Collect 
blood, colon 
and cecum 
content    
Tamoxifen ip 
for five 
consecutive 
days 
Record mice 
weight every 
2-3 days 
	   42	  
overnight.  Paraffin sections of 5µm thickness were deparaffinized and rehydrated as 
follows:  3 washes of xylene for 3 minutes; 1 wash with xylene/ethanol (50/50) for 3 
minutes; 3 washes of 100% ethanol for 3 minutes each; 3 washes of 95% EtOH (3 
mins/each); and one wash with dH2O for 2 minutes.  FISH probes were diluted with FISH 
Hybridization buffer (0.9M NaCl, 0.1M TRIS pH 7.2, 30% Formamide, 0.1%SDS) to a 
final concentration of 2.5ng/µl, and aliquotted onto each tissue section (100µL per slide).  
Slides were incubated at 37°C overnight in a humidified chamber in the dark, and then 
washed with pre-warmed (37°C) FISH Hybridization buffer for 15min.  Excess 
hybridization buffer was aspirated, and tissue samples were washed with FISH Wash 
Buffer (0.9M NaCl, 0.1M TRIS pH 7.2) for 15 minutes. Afterwards, slides were rinsed 
twice for 2 minutes with distilled water, and 4′,6′-diamidino-2-phenylindole (DAPI) was 
applied for 3 minutes as a nuclear counter-stain.  Two additional washes with distilled 
water were done, and slides were mounted using PermaFluor (ThermoScientific). 
Bacterial probes used for FISH are listed in Table 2.1.   
 
Table	  2.1	  Bacterial	  probes	  used	  for	  FISH	  analysis	  	  
Probe	   Target	   Sequence	   5’	  conjugation	  
EUB338 Universal bacterial probe 5’-GCT GCC TCC CGT AGG AGT-3’ Texas Red 
NON338 
Nonsense/non-specific 
probe 
(negative control) 
5’- ACT CCT ACG GGA GGC AGC-3’ Texas Red 
CFB286 
Chlorobi/Fibrobacteres 
Bacteroidetes 
Superphylum 
5’-TCC TCT CAG AAC CCC TAC-3’ Alexa Fluor 488 
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2.2.3.2  Hematoxylin and Eosin, Alcian Blue, Tn antigen and Lamina propria 
CD45+ cells staining 
Histological scoring for evaluation of colitis development was done based on 
epithelial hyperplasia and infiltration of CD45+ lamina propria (LP) cells into the colon 
tissue.  Hematoxylin and Eosyn (H&E) was used to address epithelial hyperplasia.  
Alcian Blue (AB) and Tn antigen staining were used to confirm mutation induction. 
Slides for H&E and AB staining were prepared following the same protocol as for FISH. 
H&E and AB were applied as established in the Core Imaging Facility of the Oklahoma 
Medical Research Foundation (OMRF) (http://imaging.omrf.org/wp-
content/uploads/2011/08/hande.pdf).  Briefly, starting with paraffin embedded section, 
the sections were washed 3 times with 100% xylene, once with 50:50 xylene and 100% 
ethanol, twice with 100% ethanol and twice with 95% ethanol.   All washes were 3 
minutes long.  The sections were rinsed with distilled water for 2-3 minutes after the 
washes.  Hematoxylin was added and incubated for 5 minutes.  Sections were washed 
under running, tap water for approximately 5 minutes and immersed in acid alcohol 
(1%HCl in 70% ethanol) until sections turned pink.  Next, sections were rinsed with tap 
water for 3 to 5 minutes and slowly immersed in ammonia water (1ml NH4OH in 1 liter 
of water) 5 to 6 times until sections darken.  Rinse step was repeated and Eosin was 
added for 1 minute.  After a final rinse with tap water, 2 minutes rinses were done as 
follows: 3 times with 95% ethanol, 3 times with 100% ethanol, once with 50:50 
xylene/100% ethanol, and 3 times with 100% xylene.  Slides were kept on xylene until 
coverslipped.   
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For Lamina propria CD45+ cells staining, 5µm formalin or Carnoy’s-fixed, 
paraffin-embedded tissue sections were deparaffinized with xylene and rehydrated 
through an ethanol gradient to water. Sections were blocked for 15 minutes using serum-
free protein block (Dako #X0909); incubated overnight at 4°C with rat-anti mouse CD45 
(Abcam #ab25386, 5ug/mL) in primary antibody dilution buffer (1°ADB) (1% BSA, 
0.1% Triton-x 100, 0.05% Tween-20 in PBS); and washed twice with 1°ADB, and twice 
with wash buffer (WB) (0.05% Tween-20 in PBS), 5 minutes/wash. Epifluorescent 
labeling for all stains was carried out using AlexaFluor 488-conjugated donkey anti-rat 
IgG (Invitrogen) in wash buffer, for 1 hr at RT in the dark, followed by rinsing in WB (3 
x 5 mins).  Samples were then fixed in 4% paraformaldehyde (PFA) in PBS for 5–10 
mins, rinsed in WB (3 x 5 mins), stained with DAPI (for DNA counterstaining), washed 3 
x 5 min in dH2O, air-dried in the dark for 20 mins, and finally mounted with PermaFluor 
(ThermoScientific). Sections were viewed on an Eclipse E1000 (Nikon) microscope.  
Protocol for Tn staining was done as described by Fu et al (2011).  Briefly, 
deparaffinized sections were incubated with or without 0.5U/ml sialidase from 
Arthrobacter ureafaciens (Roche) at 37°C for 3 hours, and subsequently incubated for 30 
minutes with biotinilated anti-Tn (mouse IgM) or with isotype-matched control IgM.  
Bound antibodies were detected with horseradish peroxidase-conjugates streptavidin 
(Vector Laboratories). 
CD45+ LP cells were stained as previously described and counted in a blinded 
fashion at 40X magnification, for 4 to 8 fields per sample, by counting all the nuclei in 
between the crypts, avoiding the nuclei associated with blood and lymphatic vessels (i.e. 
endothelial cells). Calculation of the number of epithelial nuclei in the crypts, by 
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counting 10 to 20 well-oriented crypts per section using the H&E stained slides, assessed 
epithelial hyperplasia.  The average number of intra-epithelial cells (IECs) per crypt for 
each section was obtained from the raw number of IECs.  The average number of LP 
cells and IECs for each TM IEC C1galt1-/- mice was divided by the average number 
obtained for each WT, and converted to percentage.  Scores were assigned base on 
parameters established in Table 2.2.  
 
Table 2.2 Scoring parameters for assessment of inflammation 
Parameter 
Score 
           0                     1                        2                        3 
Lamina Propria CD45+ cells per HPF 
(% WT) 
 
      ≤105%          106-125%         126-150%            ≥151% 
Epithelial Hyperplasia 
(% WT) 
 
      ≤105%          106-125%         126-150%            ≥151% 
 
 
2.2.4 Immunoglobulin measurement by ELISAs 
ELISA protocols were followed for measurement of immunoglobulins IgA, IgM, 
IgG, and the IgG isotypes IgG1, IgG2a, IgG2b, and IgG3, as described in Peterson et al 
(2007).  Briefly, plates were coated with 100µl of unlabeled goat anti-mouse (GAM) Ig 
heavy and light chain (H&L) (Southern Biotech #1010-01) diluted in bicarbonate buffer, 
and incubated overnight at 4°F.  Coating buffer was decanted, and 300µl of 1% Bovine 
Serum Albumin in PBS (BSA-PBS) were added after 3 washes with PBS-Tween (0.05% 
of Tween 20 in PBS pH7.4, PBS-T). 1% BSA-PBS was used to dilute all samples and 
standards, and PBS-T was used for all subsequent washes.  Plates were incubated for 
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30min at RT.  Subsequently, plates were washed 3 times as previously, and standards and 
samples added.  After a 2 hours incubation period at RT, plates were washed again, and 
100µl of the appropriate HRP conjugated secondary antibody added per well, followed 
by a second 2hr incubation step.    Finally, after 3 washes, 100µl of ABTS substrate were 
added per well, incubated 20min at RT, and OD read at 405nm.  Specific details of 
isotype controls and HRP-conjugated secondary antibodies are listed in table 2.3. 
 
Table 2.3 Antibodies used for Immunoglobulin ELISAS 
Igs	   Isotype	  Control	   HRP-­conjugated	  
IgA Mouse IgA unlabeled 
Southern Biotech#0106-01 
Goat Anti-mouse IgA-HRP 
Southern Biotech #1040-05 
IgG Mouse IgG unlabeled 
Southern Biotech #0107-01 
Goat Anti-mouse IgG-HRP 
Southern Biotech #1030-05 
IgG1 Mouse IgG1 unlabeled 
Southern Biotech #0102-01 
Goat Anti-mouse IgG1-HRP 
Southern Biotech #1070-05 
IgG2a Mouse IgG2a unlabeled 
Southern Biotech #0103-01 
Goat Anti-mouse IgG2a-HRP 
Southern Biotech #1080-05 
IgG2b Mouse IgG2b unlabeled 
Southern Biotech #0104-01 
Goat Anti-mouse IgG2b-HRP 
Southern Biotech #1090-05 
IgG3 Mouse IgG3 unlabeled 
Southern Biotech #0105-01 
Goat Anti-mouse IgG3-HRP 
Southern Biotech #1100-05 
IgM Mouse IgM unlabeled 
Southern Biotech #0101-01 
Goat Anti-mouse IgM-HRP 
Southern Biotech #1021-05 
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2.2.5 Data Analysis 
Statistical analysis for immunoglobulin levels and histological scores between 
genotypes (TM-IEC C1galt1-/- vs. WT) was determined by unpaired t-test with Welch’s 
correction and one-way ANOVA using GraphPad Prism 5.0 (GraphPad Software Inc., 
USA) statistical software. 
 
2.3  Results 
2.3.1 Assessment of colonization in the conventionalized 
TM-IEC C1galt1-/- mice 
 FISH staining of colon tissue confirmed absence of bacteria in the GF mice 
(Figure 2.2C) and showed robust bacterial colonization in the conventionalized mice, the 
presence of bacteria being more intense in the conventionalized TM-IEC C1galt1-/- mice 
than in the conventionalized WT (Figure 2.2A). The use of phylum-specific primers 
indicated abundance of Bacteroidetes in the conventionalized mice (Figure 2.2B).    
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Figure 2.2 Mucosa-associated bacteria increased in the conventionalized TM-IEC 
C1galt1-/- mice relative to the WT, as assessed by FISH.  [A] FISH staining using universal 
primers demonstrated robust colonization (bacteria stained in red) of the conventionalized 
(ex-germ-free) mice.     The mucosa-associated bacteria increased in the conventionalized 
TM-IEC C1galt1-/- mice [B] The use of phylum specific primers showed abundance of 
Bacteroidetes (green) in the microbiota of the conventionalized mice.  [C] FISH analysis of 
GF mice.  [A, B, C]  Note a decrease in the mucus layer (black space between bacteria-in red 
or green- and epithelial cells-in blue) in the mutated mice (bottom row) relative to the WT 
control (top row). 
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2.3.2 Assessment of mutation induction 
 Both, Alcian Blue (AB) staining and Tn antigen staining were used to assess 
mutation induction.   Figure 2.3 shows structural features analyzed through [A] AB and 
[B] Tn antigen staining for the assessment of differences between genotypes (WT vs TM-
IEC C1galt1-/-) and between treatments (GF vs conventionalized).  AB-stained colon 
tissue of both, conventionalized TM-IEC C1galt1-/- and GF TM-IEC C1galt1-/- mice, 
showed decreased number of goblet cells and a thinner mucus layer relative to their WT 
counterparts (Figure 2.4A).  Specifically for the GF setting, counting of goblet cells in the 
TM-IEC C1galt1-/- mice showed a statistically significant decrease of 20% to 30% 
(p=<0.05) in the number of goblets cells (caused by the mutation) when compared to the 
GF WT (Figure 2.5).  In addition, FISH analysis demonstrated a closer proximity of the 
microbiota to the epithelial layer in the conventionalized TM-IEC C1galt1-/- (Figure 
2.2A-B), relative to the conventionalized WT.   
The Tn antigen is a glyco-aminoacidic determinant linked to serine or threonine 
residues by a glycosidic bond (GalNAc-O-Ser/Thr).  It is masked in normal cells by type 
O saccharide chain elongation; therefore, it is expressed in some abnormal or sick cells 
when such elongation does not occur.  Upon deletion of the T-synthase enzyme 
(C1GALT1) responsible for core 1 O-glycosilation of the mucus layer, the Tn antigen 
will be detected.  Both conventionalized and GF TM-IEC C1galt1-/- mice showed 
increased presence of Tn antigen (brown staining), compared to their WT counterparts 
(Figure 2.4B). 
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Figure 2.3 Structural features analyzed for the assessment of deficiency of core 1 O-
glycans.  Note differences between the genotypes in [A] decreases in mucus production and 
the number of goblet cells (stained blue) and [B] increases in the formation of Tn antigen 
(stained brown).  
	   51	  
 
 	  	  
A 
B 
   
  G
er
m
-fr
ee
 
   
  G
er
m
-fr
ee
 
WT           
C
on
ve
nt
io
na
liz
ed
 
C
on
ve
nt
io
na
liz
ed
 
WT            TM-IEC C1gatl1-/- 
 TM-IEC C1gatl1-/- 
Figure 2.4 Good mutation induction was obtained after Tamoxifen treatment in the TM-
IEC C1galt1-/- mice as assessed by a reduction in goblet cells and increased production of 
Tn antigen.  [A] Alcian Blue staining showed a decrease in mucus production by goblet cells 
(black arrows point at goblet cells in the WT mice). [B] Tn staining (brown stain) confirmed 
an increased detection of Tn antigen in the TM-IEC C1galt1-/- mice in both, the 
conventionalized and the GF scenarios. 
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2.3.3 Development of disease in the GF TM-IEC C1galt1-/- mice 
relative to Conventionalized TM-IEC C1galt1-/- mice 
Development of colitis was monitored by the appearance of classic disease signs, 
such as development of diarrhea, weight loss and rectal prolapse.  Comparison of the 
average daily weight gain (ADG) showed higher values in the GF mice than the 
conventionalized mice.  Assessment of ADG between the genotypes (TM-IEC C1galt1-/- 
vs. WT) revealed opposite trends between the treatments: the ADG was greater in the GF 
WT mice relative to the GF TM-IEC C1galt1-/-, while in conventionalized mice the TM-
IEC C1galt1-/- showed greater ADG than the WT.  Still, no statistically significant 
changes were observed regarding weight fluctuations.  Average daily weight gain and 
standard deviations per treatment group and per genotype are listed in Table 2.4.  
Development of rectal prolapse was not observed in the conventionalized mice.  No 
major alterations in stool consistency were observed.   
Figure	  2.5	  The	  GF TM-IEC C1galt1-/- 
mice displayed a reduction of 20% to 
30% in the number of goblet cells 
relative to the GF WT mice as 
assessed through AB staining. GF mice 
inherently exhibit a decrease in the 
number of goblet cells relative to the 
conventional mice.  Interestingly, 
mutation induction further reduced the 
number of goblet cells in the GF TM-
IEC C1galt1-/- mice.  This reduction was 
estimated in 20% to 30% relative to the 
WT GF mice.	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Table 2.4 Mice average daily weight gain (ADG) and standard deviations (SD) 
per treatment and per genotype 
 
Treatment ADG WT ± SD (g) ADG KO ± SD (g) P-value 
Germ-free 0.14±0.07 0.12±0.03 0.4769 
Conventionalized 0.07±0.06 0.10±0.04 0.3511 
 
Inflammation scores (parameters for scoring presented in table 2.2) were based on 
epithelial hyperplasia and on infiltration of lamina propria CD45+ cells into the tissue, 
evaluated by H&E staining and immunolabeling of CD45+ cells, respectively.  Figure 2.6 
schemes the determination of inflammation scores. 
 
 
  Intestinal epithelia of TM C1galt1 -/- mice (20x)  
Crypts 
Lamina propria Lamina propria 
Lumen Lumen 
Epithelial  
cells 
CD45+ 
cells 
Figure 2.6 Features analyzed for the determination of inflammation scores based on lamina 
propria CD45+ cells infiltration in the tissue of the colon and epithelial hyperplasia.  The number 
of CD45+ cells was estimated by counting all the nuclei in between the crypts, avoiding the nuclei 
associated with blood and lymphatic vessels (left).  Epithelial hyperplasia was estimated by counting 
the number of epithelial nuclei in10 to 20 well-oriented crypts per section of colon (right). 
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The CD45+ marker is present in all leukocytes, making it an useful indicator of 
inflammation.  No significant differences between the germ-free genotypes (GF WT vs. 
GF TM-IEC C1galt1-/- mice) were found in the number of CD45+ cells (Figure 2.9A).  On 
the other hand, the number of CD45+ cells in the conventionalized TM-IEC C1galt1-/- 
doubled the amount of cells in the conventionalized WT counterpart, going from 30 cells 
in the WT up to 60 cells (p=0.0460) on average per field in a conventionalized TM-IEC 
C1galt1-/- sample (Figures 2.7 and 2.9A).  Appendix B includes graphs of absolute 
numbers of CD45+ cells per treatment and genotype. 
Epithelial hyperplasia refers to an abnormal increase in the number of normal 
cells that increases the volume of the intestinal epithelia. Hematoxylin will stain the 
nuclei of cells purple-blue, while Eosyn is used as a counterstain to color the cytoplasm 
and extracellular proteins in shades of pink and red.  Therefore, H&E staining allows the 
study of changes in the cellular composition of the tissue.  Statistical analysis of 
inflammation scores showed no significant differences between the genotypes in the GF 
setting.  However, the conventionalized TM-IEC C1galt1-/- mice developed moderate to 
severe inflammation, relative to the conventionalized WT counterpart, with scores values 
of 4 and 5 in a scale with a highest possible value of 6 (p<0.001) (Figures 2.8 and 2.9B).   
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Figure 2.7 Increases in the number of infiltrated lamina propria CD45+ cells were seen 
in the conventionalized TM-IEC C1galt1-/- relative to the conventionalized WT.  The 
criteria for assessment of inflammation in the colon included infiltration of CD45+ cells in 
the colon tissue. The number of CD45+ cells (stained green) in the conventionalized TM-
IEC C1galt1-/- mice doubled possibly due to an increased exposure of the microbiota to the 
intestinal epithelia caused by a breach in the mucus layer. 
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Figure 2.8 Conventionalized TM-IEC C1galt1-/- developed a high degree of 
epithelial hyperplasia.  H&E was used to assess epithelial hyperplasia in the 
colon.  Note differences in appearance of the tissue and length of the crypts in the 
conventionalized TM-IEC C1galt1-/- mice compared to the GF counterpart and 
the WT controls.   
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2.3.4 Differences in B cell responses between TM-IEC C1galt1-/- 
and WT mice in GF and conventionalized settings 
The adaptive immunity response was assessed in the GF and conventionalized 
WT and TM-IEC C1galt1-/- mice by measurement of immunoglobulin levels by ELISA.   
Immunoglobulin levels were compared between genotypes (WT vs TM-IEC C1galt1-/-), 
and within genotypes (GFWT vs conventionalized WT, and GF TM-IEC C1galt1-/- vs 
conventionalized TM-IEC C1galt1-/-) (Figure 2.10 and Table 2.5).  
A higher level of IgA in serum was found in the GF TM-IEC C1galt1-/- mice 
relative to the GF WT.  The opposite was found in the conventionalized TM-IEC 
C1galt1-/- mice were serum IgA was lower than in the conventionalized WT.   In regards 
to secretory IgA (sIgA), the levels were higher in the TM-IEC C1galt1-/- mice than in 
Lamina Propria CD45+ cells
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Figure	   2.9	   Germ-­free	   TM IEC C1galt1-/- mice did not develop inflammation. [A] The 
number of CD45+ cells in the conventionalized mice doubled possibly to an increased 
exposure of the microbiota to the intestinal epithelia caused by a breach in the mucus layer.  
[B] GF IEC C1galt1-/- mice do not develop inflammation relative to conventionalized IEC 
C1galt1-/- mice based on the established parameters. 	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WT, in both GF and conventionalized scenarios.  However, the differences were only 
statistically significant between the genotypes in the GF mice (serum IgA: GF WT 30.49 
± 1.48 vs GF TM-IEC C1galt1-/- 50.14 ± 5.43, p= 0.004; sIgA: GF WT 97.46 ± 19.62 vs 
GF TM-IEC C1galt1-/- 429.7 ± 88.29, p=0.021).  In addition, specifically for sIgA, 
statistically significant differences were found within genotypes (GF WT 97.46 ± 19.62 
vs Conv WT 1982.0 ± 407.80, p=0.019; GF TM-IEC C1galt1-/- 429.7 ± 88.29 vs Conv 
TM-IEC C1galt1-/- 2562.0 ± 477.40, p=0.021).  
 No significant differences were found in total IgG or IgG subtypes between 
treatments or between genotypes.  In spite of this, a qualitative increase in IgG1 was seen 
in the GF mice (both, WT and TM-IEC C1galt1-/-) when compared to the 
conventionalized.  These changes were proportional to reductions in IgG2b were the 
opposite occurred: higher levels of IgG2b were found in the conventionalized mice than 
in the GF.   
 Regarding IgM, levels were higher in both, the GF WT mice and the GF TM-IEC 
C1galt1-/- mice than in conventionalized mice. However, statistically significant 
differences were found exclusively for comparisons between the GF TM-IEC C1galt1-/- 
and the conventionalized TM-IEC C1galt1-/- (367.70 ± 41.61 vs 223.50 ± 36.00, 
respectively; p= 0.024). 
Table 2.5 lists the means, standard error of the means (SEM), and p-values for 
comparison between and within genotypes for each immunoglobulin measured. 
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Figure 2.10 Lack of core 1-Oglycans induced production of secretory IgA in the absence of 
microbes.  The levels of sIgA in GF mice increased when the T-synthase (C1GALT1) enzyme is 
deleted, thus creating a breach in the mucus barrier.   Conventionalization of germ-free mice induced 
increases in the levels of sIgA in the TM-IEC C1galt1-/-mice.   No significant differences were found in 
the levels of IgG or IgG isotypes between the treatments or between genotypes.  IgM levels were higher 
in the GF mice.  Lines above bars indicate significant differences between mice of different genotypes 
(WT vs TM-IEC C1galt1-/-), while letters above bars indicate significant differences between mice of 
the same genotype (GF TM-IEC C1galt1-/- vs conventionalized TM-IEC C1galt1-/- or GF WT vs 
conventionalized WT). Y-axes present real values in a log 2 scale.  Error bars represent SD. 
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2.4 Discussion 
2.4.1 Germ-free TM-IEC C1galt1-/- mice do not develop 
inflammation relative to conventionalized TM-IEC C1galt1-/- 
The typical symptoms and pathology associated with ulcerative colitis 
(development of diarrhea, rectal prolapse, weight loss, among others) were not evident in 
the conventionalized mice.  Nevertheless, in spite of such mild phenotype, we were able 
to assess the development of disease through immunological and histological changes 
associated with inflammation.  The infiltration of lamina propria CD45+ cells into 
epithelial tissue indicates an active immune response, and the increase in number on 
epithelial cells (hyperplasia) denotes the occurrence of a pathologic process.     
GF mice, regardless of their genetic constitution, are known to have a distinct GIT 
morphology and an underdeveloped, immature immune system (Thompson and Trexler, 
1971).  GF WT mice normally reveal a lower number of goblet cells and thinner mucus 
layer in the small intestine than conventional WT mice.  In the TM-IEC C1galt1-/- mice 
the induced breach in the mucus barrier caused a further reduction in the number of 
goblet cells relative to the GF WT.  However, based on the established parameters for 
assessment of inflammation, TM-IEC C1galt1-/- mice did not develop disease as long as 
they were kept germ-free, and only showed sings of inflammation when conventionalized 
through gavage of cecal contents.  Although the GF TM-IEC C1galt1-/- mice developed 
some degree of hyperplasia, the number of LP CD45+ cells found in these mice was 
equivalent to the one found in the GF WT counterpart.  Ultimately, the scores obtained 
for epithelial hyperplasia evaluation, added to those obtained from LP CD45+ cell counts, 
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did not show any significant differences between the GF TM-IEC C1galt1-/- mice and the 
GF WT counterpart.  In contrast, in conventionalized mice, deletion of the C1GALT1 
enzyme resulted in increased interactions between the microbiota and epithelial surfaces 
(as assessed by FISH), increased infiltration of LP CD45+ cells and increased epithelial 
hyperplasia, which contributed to higher inflammation scores than in conventionalized 
WT mice.  Therefore, results indicate that the microbiota, in conjunction with a breach in 
the mucus layer, has a role in disease development. 
The absence of typical symptoms associated with UC in conventionalized TM-
IEC C1galt1-/- could be attributed to a role of their genetic background in the 
pathogenesis of the disease (Mahler and Leiter, 2002; Buchler et al, 2012).  Initial 
experiments aimed to study the relationship between lack of core 1 O-glycans and the 
induction of disease were performed with C1galt1-/- originated from a 129/SvlmJ mouse 
and bred into a C57Bl/6J genetic background (Xia et al, 2004).  Even though the 
conventional TM-IEC C1galt1-/- mice used by Fu et al (2011) were generated in a 
C57Bl/6 congenic background, the mice used in our experiments were backcrossed 
additional generations into the C57Bl/6J mice. Fu’s mutated conventional mice genetic 
background was closer to 129/SvlmJ mice than a C57Bl/6J background, and 
spontaneously developed severe, typical symptoms of colitis.  However, in our system we 
found a mild disease phenotype in both, the conventionalized and monoassociated 
mutant.  Gulati et al (2012) demonstrated that the response of the two strains towards 
microbial colonization differ from one another.  The 129/SvImJ mice have decrease 
number of Paneth cells and a different profile of antimicrobial peptides relative to the 
C57BL/6J. These two factors affect the gut microbial composition and synergistically, 
	   63	  
they may act to make the 129/SvImJ strain more susceptible to disease, and development 
of inflammation.  
Additionally, the mice used in the experiments described in this dissertation were 
raised and bred in a GF setting, and as already established, the immune response of the 
GF mice is weaker than that of the conventionalized mice, and even weaker than that 
seen in the conventional setting. The combination of two factors, genetic background and 
absence of microbes, add up in disease prevention in the GF TM-IEC C1galt1-/- mice 
which is consistent with the hypothesis of the multifactorial etiology of IBD.  
 
2.4.2  Breaches in the mucus layer induce systemic and localized 
production of IgA in the absence of microbes.    
The levels of both serum and secretory IgA are, in general, higher in the 
conventionalized mice than the GF mice.  However, the differences in systemic and 
localized IgA between GF TM-IEC C1galt1-/- mice and the GF WT are by far greater 
than those found in the conventionalized setting.  In GF mice, the level of serum IgA 
almost doubled in the TM-IEC C1galt1-/- mice while sIgA increased four times (4x) 
relative to the GF WT mice.   Such changes could be explained by the enhanced exposure 
of the intestinal epithelia- and consequently the immune system- to environmental and 
diet antigens granted by the absence of microbes and the presence of a defective mucus 
layer.  In a normal, fully functional epithelial barrier, the mucus layer protects against 
exposure to foreign antigens and against chemical and proteolytic injury, thus controlling 
or preventing immune responses.   
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Overall, the Ig values found for the GF mice are in agreement to those found by 
Macpherson and Harris (2004), which were summarized in the introduction.  For both, 
WT and TM-IEC C1galt1-/- mice we found decreases in IgA and IgG in the GF mice 
when compared to the conventionalized, and relatively similar values of IgM between the 
treatments.   
Interestingly, the trends observed in the conventionalized TM-IEC C1galt1-/- are 
opposite to the Ig values obtained in patients with IBD.  The conventionalized TM-IEC 
C1galt1-/- mice had increased sIgA and decreased total serum IgG, which is contrary to 
what has been found in humans (increased IgG and decreased IgA).  These results might 
relate to our assessment of the microbiota associated with the TM-IEC C1galt1-/- mice, 
since we found the opposite of what has been found for human IBD (increases in 
Firmicutes in the TM-IEC C1galt1-/- mice, which contrast with the decreases in this 
phylum in patients with IBD).   
 
2.4.3 Bacteroidetes exist in abundance in the microbiota of the 
conventionalized mice. 
 The analysis of the microbiota in conventional core 1 O-glycans deficient mice 
relative to conventional WT mice is addressed in Chapter 3 of this dissertation.  The 
major changes found at the phylum level were increases in Firmicutes and decreases in 
Bacteroidetes, with the latter comprising up to 40% of the total microbiota.   
The use of phylum-specific primers in our FISH analysis showed abundance of 
Bacteroidetes in the conventionalized (ex-germ-free) mice.  Even though our results 
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indicated that Firmicutes were the most abundant phylum in the conventional WT and 
TM-IEC C1galt1-/-mice, it is important to acknowledge the amount of Bacteroidetes that 
the microbiota include for two reasons:  firstly, the genus Bacteroides, which belongs to 
the Bacteroidetes, is the most abundant bacterial genus in the human gut; and secondly 
and most importantly, Bacteroides species have been linked to development of 
inflammation in human and murine models of IBD (Gophna et al, 2006; Walker et al, 
2011; Andoh et al, 2011).   
Furthermore, the dissimilarities between our pyrosequencing results (addressed in 
chapter 3 of this thesis) for microbiota characterization and results obtained through FISH 
analysis might arise from differences in the environmental microbiota- and therefore, 
differences in the mice gut microbiota- since mice were bred and treated at different 
facilities.  Specifically, pyrosequencing was performed in samples from conventional 
mice housed in the mice facility of the OMRF, Oklahoma, while mice used in the 
experiments reported in this dissertation were bred in a germ-free setting, and 
conventionalized using cecal contents from the mice facility at University of Nebraska, 
Nebraska. 
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Chapter 3  
The Gut Microbiota of 
Core 1 O-glycans Deficient Mice 
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3.1  Introduction 
The mucus layer has the main function of keeping at distance the gut 
microbiota from the intestinal epithelia and mucosal immune cells.  Defects associated 
with the mucus layer disrupt the relationship between the microbiota and the host, thus 
potentially evoking immune responses against the microbiota predisposing to disease.    
The objective of the work described in this chapter was to identify changes in the 
microbiota caused by a disruption in the mucus layer, specifically by deficiency of 
core 1 O-glycans in the mucus’ composition.  
The intestinal epithelial barrier includes a monolayer of epithelial cells, 
subepithelial cells and the mucus layer. The mucus layer, in turn, consists of bioactive 
molecules, such as mucins, glycoproteins, and anti-microbial peptides, among other 
components (McGuckin et al, 2011), and it comprises an inner and an outer layer 
(Johanson et al, 2011).  Although the thickness of each of these layers varies along the 
gastrointestinal tract, the outer layer is thicker and has a lower content of Muc 2 
mucins than the inner layer.  Both, mucin content and thickness of the layers play a 
role in the spatial organization of the microbiota and the intestinal mucosa, as these 
can limit interactions between bacteria and luminal contents with epithelial cells 
(Johansson et al, 2010).  The outer layer is usually colonized by commensals and 
mucosa-associated bacteria, while the inner layer is considered sterile being devoid of 
bacteria (Johanson et al, 2008).    
O-glycans are the main component of the intestinal mucins that form the 
mucus gel layer shielding the gut epithelium (Figure 3.1).  They are usually attached 
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to serine and threonine residues in the mucin protein, and comprise up to 80% of the 
mucins’ molecular weight (Kim and Ho, 2010).  Some of their functions include 
shielding epithelial surfaces against chemical and physical damage, maintaining 
hydration of the epithelium, and serving as receptors to trap and remove bacteria.  
They may also affect the conformation of the protein to which they are attached, thus 
affecting its function (Varki and Lowe, 2009).   
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Figure 3.1 O-glycans are the main component of the intestinal mucins that 
form the mucus gel layer shielding the gut epithelium.  O-glycans are usually 
attached to serine and threonine residues in the mucin glycoprotein backbone.  
They comprise up to 80% of the mucin’s molecular weight.   
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Defects in the mucus layers and their O-glycans may arise from mutations in 
the mucin genes, lack of mucin proteins, and deletions of the glycosyltransferase 
enzymes needed for mucus synthesis and O-glycans attachment.  A primary defect in 
mucus synthesis could lead to a breach in the epithelial barrier, allowing closer contact 
between commensals and immune cells.  Consequently, altered mucosa-bacteria-
immune cells interactions will ensue.  Indeed, a subset of UC patients have been 
shown to have impaired expression of intestinal mucin-type O-glycans due to 
mutations in C1galt1C1, a chaperone protein (also known as cosmc protein) required 
by the core 1 β1,3-galactosyltransferase (also known as T-synthase) needed for core 1 
O-glycans attachment (Podolsky et al, 1988; Holmen Larsson et al, 2011, Fu et al, 
2011).  However, the function of these carbohydrate moieties in the etiology of the 
disease remains unclear.  In the absence of O-glycans, the protective functions of the 
mucus layer are lost and susceptibility to disease is increased, as it has been shown in 
conventional mice lacking core-1 O-glycans, which spontaneously develop colitis (Fu 
et al, 2011). 
A second source of mucosal defects may arise from the ability of bacteria and 
pathogens to adapt and interact with mucus (Derrien et al, 2004; Cervantes-Sandoval, 
2008; Gaskell et al, 2010; Martens et al, 2011; Van den Abbeele et al, 2011).  
Degradation of the mucus layer by bacterial enzymes, such as glycosydases, may 
affect mucus integrity increasing the degree of interaction between the intestinal 
epithelia and bacteria, bacterial products or luminal substances.  Such changes may 
prompt inflammatory disorders.  Furthermore, changes in bacterial factors during the 
progression of inflammation may also influence mucus synthesis and expression.  In 
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turn, impaired mucus synthesis could have adverse effects on the immune system and 
the microbiota, contributing to the perpetuation of inflammation.   
Differences in pathological changes in mucus expression have been found 
between UC and CD (Einerhand et al, 2002; Gersemann et al, 2009; McGuckin et al, 
2011).  While the thickness of the mucus layer and the number of goblet cells either 
remain unchanged or are increased in CD, both of these elements are reduced in UC 
(Pullan et al, 1994; Strugala el at, 2008).  Both patterns of change have an impact in 
the number of bacteria present in the colon, as some constituents of the microbiota live 
in close association with the mucus layer and contribute to niche establishments for 
other members of the intestinal flora (Png et al, 2010). Accordingly, preserving mucus 
components and the mucus layer, is essential in its role as a barrier.   We hypothesize 
that when the mucus layer is destroyed by inflammation, genetic loss, or 
overconsumption by gut bacteria, these changes can result in increased inflammatory 
signaling and, eventually, colitis.   
Aiming to characterize changes in the gut microbiota associated with a breach 
in the mucus layer caused by lack of O-glycans, we performed molecular analysis of 
fecal bacterial populations by pyrosequencing of 16S rRNA tags of conventional TM-
IEC C1galt1-/- mice.  The TM-IEC C1galt1-/- mice have an inducible mutation of the 
glycosyltransferase enzyme responsible for attachment of core 1O-glycans to the 
mucin backbone, which results in a thinner mucus layer, thus resembling human 
Ulcerative Colitis (UC).   The identification of specific bacterial taxa in IBD could be 
a stepping-stone in the development of appropriate antimicrobial therapies against 
pathobionts while preserving beneficial commensals. 
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3.2 Materials and Methods 
3.2.1 Sample collection from conventional TM-IEC C1galt1-/- 
mice. 
Samples were collected from four conventional wild type mice, and four 
conventional TM-IEC C1galt1-/- mice kept in a specific pathogen-free facility at the 
Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma.  
Samples included fecal pellets (FP), cecal contents (CC) and left colon contents 
(LCC), and they were kept at -80°F until processed for DNA isolation in the Peterson 
laboratory.  
 
3.2.2 DNA Isolation 
Samples (FP, CC and LCC) were weighted and diluted in phosphate buffer 
(pH7) in a 1:10 ratio, followed by centrifuging at 10,000rpm (Eppendorf 5424) for 5 
minutes.  This washing step was repeated two more times to remove inhibitors.  
Bacterial cell pellets were resuspended in 750µl of lysis buffer (200mM NaCl, 20mM 
EDTA, 100mM Tris [pH 8.0], 20 mg/ml lysozyme), transferred to a sterile 
microcentrifuge tube containing 300mg of 0.1mm zirconium beads, and incubated at 
37°C for 30min.  Afterwards, 85µl of 10% sodium dodecyl sulfate solution and 40µl 
of proteinase K  (15mg/ml) were added, and tubes were incubated at 60°C for 30min.  
After incubation, 500µl of phenol-chloroform-isoamyl alcohol (25:24:1) were added, 
and samples were homogenized in a MiniBeadbeater-8 (BioSpec Products) at 
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maximum speed for 2 minutes, followed by cooling in ice.  Layers were separated by 
centrifugation at 14,000rpm for 5min before extraction of the top layer.  This step was 
repeated three times with phenol:chlorofom:isoamyl, and twice with chloroform-
isoamyl alcohol (24:1).  DNA was recovered by inducing precipitation through the 
addition of 100% ethanol and 3M sodium acetate.  The amount of eluting reagents 
used depended on the final volume of sample obtained after the last extraction step 
(2.5 times of ethanol per volume of sample and 1/10 volume of sample of 3M sodium 
acetate).  Samples were stored at -20°F overnight followed by centrifugation at 
14,000rpm (Eppendorf 5424) for 30min.  Ethanol was discarded, DNA pellets were 
allowed to dry at room temperature, and resuspended in 100µl of 10mM Tris-HCL 
buffer (pH8).   
 
3.2.3 Pyrosequencing of 16S rRNA PCR 
The variable regions 1 and 2 of the 16s rRNA genes were amplified by PCR 
using a composite forward primer and a reverse primer containing a unique 12-base 
barcode to tag PCR products to their respective samples.  The primer sequences used 
were as follows: 454_27F 5’-
GCCTTGCCAGCCCGCTCAGTCAGTCAGAGTTTGATCCTGGCTCAG-3’ and 454_338R 5’-
GCCTCCCTCGCGCCATCAGNNNNNNNNNNNNCATGCTGCCTCCCGTAGGAGT-3’; where 
the italicized sequences are the 454 Life Sciences primers B and A, and the bold 
sequences are the broadly conserved bacterial primer 27F and the broad-range 
bacterial primer 338R, respectively.  The NNNNNNNNNNNN region in the reverse 
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primer represents the unique 12-base barcode used to tag each PCR product with a 
“CA” inserted as a linker between the barcode and the reverse primer.  PCR conditions 
were: 5mins at 95°C; followed by 30 cycles of 45s at 95°C, 45s at 57°C, and 2min at 
72°C; and lastly 10min at 72°C in an Eppendorf Mastercycler thermocycler.  PCR 
products were visualized by gel electrophoresis.  Amplicons from individuals samples 
were mixed in equal amounts based on concentration, and purified using the QIAGEN 
MiniElute Gel extraction kit (QIAGEN #28604).  The final, purified product, with a 
concentration of 29.99ng/ml was submitted to emulsion PCR and sequenced using a 
Roche 454 FLX pyrosequencer at the Cornell University Life Sciences Core 
Laboratories Center.  Sequences obtained from pyrosequencing were filtered and 
submitted to quality control parameters.  
 
3.2.4 Data Analysis and Statistics  
Sequences generated from pyrosequencing were submitted to the open source 
software package Quantitative Insights into Microbial Ecology (QIIME; 
http//qiime.source-forge.net) for removal of low quality sequences.  Sequences that 
met the following parameters were kept for analysis: (i) length between 340 and 400 
nucleotides; (ii) no ambiguous bases; (iii) quality score equal or above 25; (iv) no 
mismatches in primers; and (v) no mismatches in barcodes.   After sequences were 
quality controlled, chimera check was performed using the Chimera Slayer method in 
QIIME and binned by barcode.  Taxonomic-based analysis was performed using the 
Classifier (Wang et al, 2007) program of the Ribosomal Database Project (RDP) 
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version 9 (Cole et al, 2009) (http://rdp.cme.msu.edu/) to assign taxonomic status to 
each sequence.  Significance of the Classifier data was determined by calculating 
proportions and statistical analysis performed by calculating the average mean of 
proportions and Fisher’s Z score (Appendix A) using a critical value of 3.29 
(α=0.001).     
Taxonomic-independent methods were used to estimate species diversity.  
Sequences were aligned and clustered using the Aligner and Complete Linkage 
Clustering algorithm available through the Pyrosequencing pipeline of the RDP.  
Clustering was done with a threshold of 97% pairwise identity for assignment into 
operational taxonomic units (OTUs).   Initial clustering of the sequences in the dataset 
by Complete Linkage Clustering produced a total of 3,641 OTUs.  After selecting 
representative sequences for each OTU, a single best BLAST hit was identified for all 
sequences in the dataset using BioEdit Blastall function by blasting them against the 
dataset of non-chimeric sequences.  OTUs over 300 bases long, over 97% identity, and 
containing more than 100 hits in total were kept for analysis.  This filtering step 
produced a total of 891 OTUs.  A new set of representative sequences was selected 
from the group of 891 OTUs, and the blasting step was repeated.  Sequences that 
overlapped between OTUs were determined by comparing the sequences that 
comprise each OTU, and were merged together, resulting in 206 OTUs, from which 
representative sequences were selected and blasted against the dataset.  Hits were 
counted using Excel.  The filtering step was repeated as before producing a total of 
184 unique OTUs. Proportions were calculated and significance of the OTUs was 
determined by calculating the average mean of proportions and Fisher’s Z score 
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(Appendix A).  A critical value of 3.29 (α=0.001) was selected to determine statistical 
significance.  Taxonomy was assigned for each OTU representative sequence by 
selecting the Best Blast result from a local type strain database using BioEdit Blast. 
Additionally, representative sequences from each OTU were aligned using 
PyNast, and used to construct a reference phylogenetic tree through QIIME.  This 
phylogenetic tree was used for Unweighted UniFrac analysis.  Rarefaction analysis 
was performed using the Pyrosequencing pipeline of the RDP after alignment and 
complete linkage clustering of the sequences for individual samples. 
 
3.3 Results  
3.3.1. Diversity assessment and comparisons between microbial 
communities by non-taxonomic-based analyses: UniFrac, 
Principal Component Analysis, Rarefaction, Shanon and 
Chao indexes 
To determine whether lack of core 1 O-glycans caused proportional changes in 
the gut microbiota of the mice, we analyzed fecal pellets (FP), cecal contents (CC), 
and left colon contents (LCC) of conventional TM-IEC C1galt1-/- (KO) mice (n=4) 
and conventional wild type (WT) mice (n=4) by pyrosequencing of the V1-V2 region 
of the 16S rRNA gene.  A total of 406,339 reads were obtained, which, after 
submission to quality control parameters and chimera check, resulted in 279,912 
sequences that were used in the analysis.  One sample (fecal pellets from a wild type 
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mouse) was dropped from the analysis because of poor amplification of reads.  The 
percentage of chimeric sequences removed was 16.4%.  The average number of 
sequences per sample was 12,170 sequences with an average length of 370bp.   
 
3.3.1.1 UniFrac and Principal Component Analysis 
Unweighted UniFrac is a metric for distance between communities of 
organisms that takes into consideration absence or presence of Operational Taxonomic 
Units (OTU), but not their abundance (Lozupone et al, 2006).  It accounts for unique 
OTUs and their branch length.  Principal Component Analysis (PCoA) is a variable 
reduction procedure that finds linear combinations of a set of variables with maximum 
variance and removes their effect, repeating this successively to eliminate redundancy 
or variable correlation with one another.  The purpose is to avoid measuring the same 
construct more than once.  Unweighted UniFrac and PCoA were performed for all 
samples to assess differences in microbial composition between the samples.  
Analyses showed differences in bacterial communities between the genotypes TM-
IEC C1galt1-/- vs WT, specifically in the LCC.  Principal Component 1 (PC1) accounts 
for 26.83% of the variability in the data, and PC2 accounts for 18.6% in the LCC 
(Figure 3.1A).  The UniFrac phylogenetic tree showed a distinct microbial population 
in the LCC of the conventional TM-IEC C1galt1-/- mice when compared to the 
conventional WT (Figure 3.2A).  However, these differences were not seen in the 
fecal pellets or in cecal contents of the mice (Figure 3.2B-C). 
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3.3.1.2 Rarefaction and Shannon and Chao indexes  
Rarefaction curves (Figure 3.3) and Shannon and Chao indexes (Figure 3.4) - 
methods for assessment of species diversity - showed that the most diverse microbiota 
is found on the cecum of the conventional WT mice, followed by cecum samples of 
the TM-IEC C1galt1-/- mice.  Similarly, the WT LCC samples were more diverse than 
the LCC TM-IEC C1galt1-/- samples.  There was no change in diversity between the 
WT and the TM-IEC C1galt1-/- fecal samples.  However, no statistically significant 
differences (p >0.05) in diversity were found between genotypes within each 
anatomical site sampled or between anatomical sites.  It is necessary to take into 
consideration that rarefaction curves consider the number of species in a sample, but 
do not account for specific taxa present (as opposed to Unweighted UniFrac). 
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Figure 3.2 Unweighted UniFrac and Principal Component analyses reflect two distinct 
microbial communities in the left colon content in the TM-IEC C1galt-/- relative to the 
WT mice.  Unweighted UniFrac (non-abundance) cluster trees and PCoA graphs are shown 
for [A] cecal samples, [B] fecal pellets, and [C] left colon content.  These analyses were 
performed to assess similarities in microbial communities between the genotypes.  The 
microbial communities from cecal contents and fecal pellets of WT and TM-IEC C1galt1-/- 
mice share similarities in composition.  However, two distinct microbial communities were 
observed in LCC samples between the genotypes.  KO: TM-IEC C1galt-/- mice, Red dots and 
lines represent the WT mice.  Green dots and lines represent the TM-IEC C1galt-/- mice.	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Figure 3.3 Rarefaction graphs for analysis of species diversity in the different anatomical sites 
showed no statistically significant differences between the genotypes.  It is necessary to take 
into consideration that rarefaction curves consider the number of species in a sample, but do not 
account for specific taxa present, which is contrary to Unweighted UniFrac. Red lines represent the 
WT mice.  Green lines represent the TM-IEC C1galt-/- mice.	  
 	  
Figure 3.4 Microbial diversity decreased in the cecal contents and left colon contents of 
the TM-IEC C1galt1-/- mice relative to the WT.  The most diverse microbiota was found in 
the cecal contents of the WT mice followed by the cecal contents of the TM-IEC C1galt1-/- 
mice.  Same trend was observed in the LCC samples (higher diversity found in the WT 
samples than the mutant).  However, no differences in diversity were found in the microbial 
communities of the fecal pellets between WT and TM-IEC C1galt1-/-. Shannon index 
increases as both, richness (abundance) and evenness of the community increases. Higher 
Chao1 index values means higher diversity. 
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3.3.2  Taxonomy-based analysis of the microbial communities 
The RDP Classifier is a simple probabilistic (naïve Bayesian) classifier that 
provides rapid taxonomic assignments, from domain to genus, to bacterial 16S rRNA 
sequences.   After submission of the sequences to Classifier, the total of sequences per 
taxa per sample were summarized at different taxonomic levels, and proportions were 
calculated.  Significance of the Classifier data was determined, as mentioned in the 
methods section, using a critical value of 3.29 (α=0.001) to assess significance of 
results.   
 
3.3.2.1 Phylum 
Taxonomy-based analysis at the phylum level showed a significant increase in 
the number of Firmicutes and a decrease in the number of Bacteroidetes in the TM-
IEC C1galt1-/- relative to the WT (Figure 3.5).  Firmicutes increased, on average, from 
43.6% in the WT mice to 52.8% in the TM-IEC C1galt1-/- mice, while Bacteroidetes 
decreased from 41.1% to 34.4%.  These changes were greater in the FP, were 
Firmicutes increased from 38.6% to 60.4% (Z=15.20), and Bacteroidetes decreased 
from 44.4% to 27.0% (Z=-12.79).  A smaller change in the number of Firmicutes was 
found in LCC samples were they increased from 42.6% in the WT mice to 47.7% in 
the TM-IEC C1galt1-/- mice (Z=4.12) (Figure 3.5).  These differences were not 
observed in CC samples of the mice. 
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3.3.2.2 Family 
At the family level, significant increases were found in the conventional TM-
IEC C1galt1-/- mice, specifically in the amount of Lactobacillaceae and Clostridiaceae 
in all types of samples.  In LCC, Lactobacillaceae increased from 14.3% to 28.7% 
(Z=14.2871), while Clostridiaceae increased from 0.016% to 1.022% (Z=5.9574).  
The number of Prevotellaceae decreased in FP and CC samples, but remained 
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Figure 3.5 RDP Classifier analyses at the Phylum level showed that deficiency of Core 1 
O-glycans causes significant increases in Firmicutes and decreases in Bacteroidetes in the 
fecal pellets of the mice.   An increase of 22% in Firmicutes and a relative decrease of 17% in 
Bacteroidetes were found in the fecal population of the TM-IEC C1galt1-/- mice relative to the 
WT.  Similar changes at a minor extent were seen in LCC samples.  However, they were not 
observed in the contents of the cecum. 
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unchanged in LCC samples.  Ruminococcaceae changes in CC or FP were not 
significant; however, in LCC this taxon decreased to almost half its value, from 4.49% 
to 2.64% (Z=-3.9675).  Lachnospiraceae was found decreased in both, FP and LCC, 
with the greater reduction in LCC, were its number changed from 7.09% to 3.55% 
(Z=-6.2343).  Another taxonomic group found diminished were the unclassified 
Clostridiales (from 6.82 to 4.48%, Z=-4.03).  Figures 3.6 and 3.7 show results at the 
Family level. 
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Figure 3.6 The net change in the population of Firmicutes at the Family level is the result 
of increases in Clostridiaceae and Lactobacillaceae, and decreases in Ruminococcaceae 
and Lachnospiraceae. Clostridiaceae and Lactobacillaceae consistently increased in all 
anatomical sites in the TM-IEC C1galt1-/- mice. Pie charts represent the abundance (in 
percentage) of bacterial families present in each anatomical site per genotype.  	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3.3.2.3 Genus 
At the genus level, significant changes were found in LCC samples on 
populations of Lactobacillus, Clostridium, unclassified Lachnospiraceae, and 
unclassified Ruminococcus (Figures 3.8 and 3.9C).  The predominant change was in 
the population of Lactobacillus, which increased from 14.26% to 28.67% (Z= 14.29).  
Clostridium also increased changing from 0.01% to 0.89% (Z= 5.56).  Changes in 
these two groups of bacteria were found in all anatomical sites (Figure 3.9).  
Unclassified Lachnospiraceae diminished in LCC samples from 6.23% to 3.03% (Z=-
6.00). Lastly, unclassified Ruminococcaceae decreased in all types of samples but 
changes were only significant in LCC (from 2.87 to 1.49; Z=-3.7391).  Figure 3.8 
presents the taxonomic analysis at the genus level for all anatomical sites tested. 
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Figure 3.7 Anatomical site-specific 
microbial decreases at the family level 
were found in the TM-IEC C1galt1-/- 
mice.   Statistically significant decreases 
in [A] Prevotellaceae were found 
exclusively in the cecal contents, [B] 
unclassified Bacteroidales were found 
exclusively in the fecal pellets, while 
decreases in [C] Ruminocccaceae were 
found exclusively in the LCC of the TM-
IEC C1galt1-/- mice. 	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Figure 3.8 Increases in Clostridium and Lactobacillus spp. were found in all 
anatomical sites of the core 1 O-glycans deficient mice being the Lactobacillus 
population the most affected at the Genus level.  Pie charts represent percentage of 
bacteria by anatomical site and per genotype. 	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3.3.2.4 Operational Taxonomic Units  
Initial clustering of sequences in the dataset by Complete Linkage Clustering 
of the RDP produced a total of 3,641 Operational Taxonomic Units (OTUs) using a 
97% similarity threshold.  After merging overlapping OTUs, and counting of Best 
Blast hits (as discussed in the methodology), a total of 184 unique OTUs were left for 
analysis, which accounted for 97.6% of the sequences.  Similar to Classifier analysis, 
significance of the OTUs data was determined by calculating the average mean of 
proportions and Fisher’s Z score using a critical value of 3.29 (α=0.001) to assess 
importance of results.  
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Figure 3.9 Anatomical site-specific 
microbial decreases at the genus level were 
found in the TM-IEC C1galt1-/- mice.   
Statistically significant decreases in [A] 
unclassified Prevotellaceae were found 
exclusively in the cecal contents, while 
decreases in [C] unclassified 
Ruminocccaceae were found exclusively in 
the LCC of the TM-IEC C1galt1-/- mice. 	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Examination of OTUs defined by 97% identity resulted in 19 OTUs 
significantly different between the genotypes (WT vs TM-IEC C1galt1-/-) when 
considering all anatomical sites (Table 3.1). However, 8 OTUs (Figure 3.10) were 
specifically significant in LCC samples. Three OTUs, representing clusters associated 
to Lactobacillus intestinalis (97% identity), Lactobacillus johnsonii (99% identity), 
and Clostridium disporicum (97% identity), resulted statistically different in all sites, 
being considerably increased in the conventional TM-IEC C1galt1-/- mice. The number 
of Lactobacillus johnsonii doubled in LCC from 13.60% to 25.79% (Z=12.34), while 
Lactobacillus intestinalis increased to almost four times from 1.29% to 3.77% 
(Z=6.43).  Clostridium disporicum increased from less than 0.02% in conventional 
WT mice samples to 1.08% (Z= 6.01) in the conventional TM-IEC C1galt1-/- mice.   
   
 
 
Figure 3.10 Statistical analyses of OTUs showed changes in 8 OTUs specific to the LCC 
of the TM-IEC C1galt1-/- mice.  These OTUs are represented by Clostridium disporicum, 
Lactobacillus intestinalis, Lactobacillus johnsonii, which are increased in the LCC of the 
mice; and Anaerotruncus colihominis, Allobaculum stercoricanis, Eubacterium biforme and 
Parabacteroides distasonis, which are decreased in the mice colon. 
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The remaining OTUs that were found significant in the distal colon were 
reduced in the conventional TM-IEC C1galt1-/- mice relative to the conventional WT, 
some of them having over a ten-fold reduction.  These were: OTU11, whose nearest 
neighbor (NN) shares 94% identity with Parabacteroides distasonis, reduced from 
1.34% to 0.45% (Z=-3.6872) and OTU19122 NN (96% identity to Anaerotruncus 
colihominis), from 0.73% to 0.09% (Z=-3.8169).  Additionally, three OTUs form the 
family of Erysipelotrichaceae were reduced: Eubacterium biforme (97% identity), 
from 12.66 to 9.35% (Z=-4.18); OTU770 NN (94% identity to Eubacterium biforme), 
from 0.61% to 0.06% (Z=-3.6155); and OTU15434 (91% identity to Allobaculum 
stercoricanis) from 2.98% to 0.28% (Z=-8.1531).  Proportions and Z-values (for 
statistic significance) per anatomical site for all OTUs are given in Table 3.1. 
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3.4 Discussion 
3.4.1 Distinct microbial communities are associated with the 
conventional colitic TM-IEC C1galt1-/- mice  
Changes between microbial communities were found in the conventional TM-
IEC C1galt1-/- mice relative to the conventional controls mice (WT). Summarizing, 
these changes mainly include increases in Firmicutes spp. and reductions in 
Bacteroidetes spp. in core 1 O-glycans deficient mice.  
Sonnenburg et al (2004) propose that commensals dwell in the mucus layer by 
overlying the gut epithelium through the formation of a “biofilm-like community”.  
They define biofilms as “dense cohesive communities of microbes that embed 
themselves within surface-associated matrices”.  The surface-associated matrix 
referenced is the one formed by the carbohydrate polymers in the mucus layer.  As 
previously described, the TM-IEC C1galt1-/- mice have an incomplete, thin mucus 
layer.  Consequently, they have a defective matrix for microbes to establish 
themselves.  Accordingly, changes in the microbiota could be explained by a decrease 
in sites for bacterial attachment.   
Furthermore, since some bacteria are capable of inducing inflammation 
(Waidmann et al, 2003; Balish and Warner, 2002; Kim et al, 2005), the development 
of inflammation in the colon, and other related immune changes (i.e. induction of 
proinflammatory cytokines and cell-mediated responses) could affect niche 
establishments for some members of the microbiota.   
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3.4.2 Lactobacillus and Clostridium populations are enriched in 
conventional colitic TM-IEC C1galt1-/- mice  
Some studies in human UC have observed a decrease in Firmicutes (Sokol et 
al, 2006; Walker et al, 2011).  In the conventional TM-IEC C1galt1-/- mice model 
there is an increase in this group, which more specifically are the net result of 
increases in Clostridium and Lactobacillus, despite decreases in unclassified 
Ruminococcaceae and unclassified Lachnospiraceae at the genus level.  Results from 
our mice model show evidence that parallel results from other human studies, since 
both Ruminococcus spp. (in CD) and Lachospiraceae spp. (in UC and CD) were found 
decreased in IBD patients (Frank et al, 2007; Morgan et al, 2012). 
The most significant alteration within the Lactobacillus was an increase in L. 
johnsonii.  This is consistent with the work of Peña et al (2004), where isolates of this 
species were found to predominate in the IL-10 deficient C57BL/6 mice model of 
colitis and in which some Lactobacillus species isolated from these mice were unable 
to inhibit TNF-α while others could.  In contrast, some L. johnsonii strains have been 
able to mitigate the effect of other bacteria in colitis induction, prevent disease 
development in murine models of cirrhosis and diabetes (Chiva et al, 2002; Valladares 
et al, 2010; Lee and Kim, 2011), and ameliorate inflammation in human and mice 
models of colitis, or DSS-induced injury of the colon (Liu et al, 2011; Oliva et al, 
2012; Duary et al, 2012; Jadhav et al, 2013).  
In regards to the Clostridium group, OTU analysis revealed that C. disporicum 
was found increased in the conventional TM-IEC C1galt1-/- mice in the OTU analysis.  
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This finding is in partial agreement with work from Milonaki et al (2005) who found 
Clostridium spp. increased in active UC.  However, in general, studies have found a 
decrease in Clostridium spp. in human UC, especially in the Clostridium leptum 
group, to which F. prausnitzii belongs, and to whom a protective role in CD has been 
credited by some researchers (Sokol et al, 2009; Joossens et al, 2011; Morgan et al, 
2012; Kabeerdoss et al, 2013).  Other species of Clostridium, such as C. butyricum 
and C. tyrobutyricum, have been found to decrease colon inflammation induced by 
DSS (Zhang et al, 2009; Hudcovic et al, 2012).  
Since our experiments were specifically aimed at the identification of taxa 
affected by core 1 O-glycans deficiency, these results do not allow us to ascribe a 
specific role for L. johnsonii or C. disporicum in our mice model in terms of whether 
their enrichment is a cause of lack of O-glycans, or a consequence of inflammation.   
 
3.4.3 Eubacterium biforme and Anaerotruncus colihominis, two 
butyrate-producing bacteria, are decreased in 
conventional colitic TM-IEC C1galt1-/- mice 
Short-chain fatty acids (SCFA), which include propionate, butyrate, and 
acetate, among others, are metabolic products of microbial fermentation with an 
important role in colonic health (Reviewed by Hijova and Chmelarova, 2007).  The 
anti-inflammatory capacities of SCFA, especially butyrate, have been tested in vitro 
and in vivo, and are well documented (Steinhart et al, 1996; Tedelind et al, 2007).  In 
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addition, butyrate was identified as the preferred energy source for colonic epithelial 
cells (Roediger, 1980).   
Both, E. biforme (Barcenilla et al, 2000) and A. colihominis (Lawson et al, 
2004) have been characterized as butyrate-producing bacteria, and both of these were 
found decreased in the conventional TM-IEC C1galt1-/- mice relative to conventional 
WT.  They are members of the phylum Firmicutes:  the first one belongs to the order 
Erysipelotrichales, family Erysipelotrichaceae; while the latter belongs to the order 
Clostridiales, family Ruminococcaceae and it is part of the Clostridium leptum group.  
Some species of Eubacterium, one of the most common genera in the human intestine 
(Schwiertz et al, 2002) have been reported as capable of attenuating experimental 
colitis (Kanauchi et al, 2005).  
Eubacterium biforme, which represents OTU number 6028 (97% identity) in 
our assessment, was found an average of -1.5 fold decreased in the conventional TM-
IEC C1galt1-/- considering all anatomical sites tested (Table 3.1).  Fecal pellets 
showed the most significant change, were it decreased from 17.56% in the WT mice to 
10.59% (-1.7 fold decrease) in the TM-IEC C1galt1-/- mice.  The changes in A. 
colihominis, which represents OTU 19122, were not as significant considering its low 
abundance in the mice.  Still, decreases in both of these species may affect the total 
amount of butyrate available for epithelial cells and therefore, potentially contribute to 
loss of epithelial integrity.   
Besides being a major nutrient source for colonocytes, SCFA constitute a 
source of nutrients for various members of the microbiota, serve as modulators of 
colonic and intracellular pH, and ion transport, and they are regulators of proliferation, 
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and differentiation (reviewed by Cook and Sellin, 1998).  In addition, SCFA stimulate 
gene expression, including expression of epithelial mucin 2 proteins (Willemsen et al, 
2003).  Since loss of butyrate-producing bacteria would imply destabilization of all 
these processes, it is to be expected that loss of the epithelial barrier function, and 
further dysbiotic shifts would follow, thus predisposing to disease development.  
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Chapter 4 
Colitogenic Bacterial Species in 
Core 1 O-glycans Deficient Mice 
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4.1 Introduction 
Animal models are designed to resemble specific aspects of human diseases with 
the objective of elucidating the etiology of such disorders, and develop appropriate 
treatments. The main objective of the set of experiments described in this chapter was to 
identify bacterial species with the potential of inducing inflammation in the TM-IEC 
C1galt1-/- (core 1 O-glycans deficient) mice model.  The core 1 O-glycans deficient mice 
model, in which the intestinal mucus layer is thinner than normal, presents a simplified 
version of Ulcerative Colitis (UC), as it has been shown that a subset of UC patients have 
this anatomical anomaly (Einerhand et al, 2002; Fu et al, 2011).   
The characterization of microbial species inhabiting the GIT of IBD patients is 
done with the purpose of identifying causative bacteria of inflammation and to develop 
the appropriate antimicrobial therapies.  Even though there is no consensus on the 
identification of specific bacterial species as causative of IBD, several species have been 
categorized either as “colitogenic” or as “preventive/protective” in a number of colitis 
murine models.  Interestingly, bacterial species that have been associated with induction 
of inflammation in some models have been shown to have the opposite effect in others.  
For example, Bacteroides vulgatus was identified as an inducer of inflammation in the 
HLA-B27 transgenic rat model, but as “preventive” in the IL-2-/- mice model of colitis.  It 
can be hypothesized that the pathogenicity of particular bacterial species varies 
depending on the type of genetic deficiency (immunological or physiological) introduced 
into the animal model to resemble the human disease.   Examples of “inducers” and “non-
inducers” of inflammation for various murine models are listed in table 4.1 
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Table 4.1 Inflammation inducer and non-inducer bacterial species in selected murine models of 
colitis and chemically-induced injury of the colon 
 
Mice 
model 
Inducer bacterial 
species 
Non-inducer bacterial 
species Settings References 
IL-2-/- E. coli mpk B. vulgatus mpk GF 
Waidmann et al, 2003 
Muller et al, 2008 
IL-2-/- E. coli mpk 
E.coli Nissle 1917 
B. vulgatus mpk 
SPF Bohnn et al, 2006 
HLA-B27 B. vulgatus ND GF Rath et al, 1999 
IL-10-/- H. hepaticus ND SPF Kullberg et al, 1998 
IL-10-/- E. faecalis 
Bifidobacterium spp. 
Specific Lactobacillus 
spp 
GF Balish and Warner, 2002 
IL-10-/- ND L. plantarum 299V GF & SPF Schultz et al, 2002 
IL-10-/- E. faecalis P. fluorescens GF Kim et al, 2005 
IL-10-/- ND L. plantarum LP-Onlly Conv. Xia et al, 2011 
DSS 
injury Y. enterocolitica B. adolescentis Conv. Frick et al, 2007 
TNBS 
injury ND 
B. longum HY8004 
L. plantarum AK8-4 
Conv. Lee at al, 2009 
TNBS 
injury K. pneumoniae L. johnsonii Conv. Lee and Kim, 2011 
Abbreviations-  GF: Germ-free, SPF: Specific pathogen-free, Conv: Conventional, ND: not 
determined, DSS: Dextran sodium sulfate, TNBS: 2,4,6-trinitrobenzene sulfonic acid 
 
We performed monoassociation experiments of GF WT and GF TM-IEC C1galt1-
/- mice with selected bacterial species.  The purpose of these experiments was to 
determine bacterial species associated with the development of inflammation in the 
context of a defective mucus layer. Species were chosen either based on their reported 
association with development of inflammation in murine models of colitis, or because 
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they were identified in our work as altered in the conventional TM-IEC C1galt1-/- mice, 
such as Lactobacillus johnsonii, among others (addressed in Chapter 3). 
  
4.2 Materials and Methods 
4.2.1 TM-IEC C1galt1-/- mice 
Mice for monoassociation experiments were genotyped and selected for each 
bacterial treatment as discussed in Chapter 2.  Mice were colonized by orally gavaging 
200µl of oxygen-sensitive bacterial species in pure cultures, or by rubbing cultures of 
oxygen-tolerant bacterial species onto the mouse fur (Bry et al, 1996).  Deficiency of 
intestinal O-glycans was induced 48 to 72 hours after colonization by intraperitoneal 
injections of 100 µl of 1mg of Tamoxifen (TM; MP Biomedicals) in an ethanol/sunflower 
oil mixture (1:9 v/v) for 5 consecutive days.  For both, WT controls and TM-IEC 
C1galt1-/- mice, TM treatment was completed before the mice were 8 weeks old.  Mice 
were sacrificed either 20 days or 30 days after TM injections depending on the bacterial 
species used for colonization.  Mice weights were monitored and recorded every other 
day. A group of Germ-free (GF) TM-IEC C1galt1-/- and GF WT mice used as negative 
controls (non-colinized mice), were also treated with TM, and sacrificed at 20 or 30 days.  
A vehicle-control group - treated with ethanol/sunflower oil without TM) - was not used 
since TM injections were administered to both WT (Cre-) and TM-IEC C1galt1-/- (Cre+) 
mice. Figure 4.1 shows a schematic representation of the methodology used for the 
bacterial monoassociation experiments. 
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4.2.2 Bacterial species 
The selection of bacterial species used for the monoassociation experiments was 
based on its identification, by pyrosequencing analysis (discussed in Chapter 3), as 
significantly altered in the conventional TM-IEC C1galt1-/- mice, or by being described 
by other authors as “colitogenic” or inflammation inducers in various murine models of 
UC.  Additional species, not associated with development of inflammation, were selected 
as “control strains” (Table 4.2).   
All the bacterial species used in monoassociation experiments were grown in an 
anaerobic chamber with environmental conditions set as follows: 37°C, 5% CO2, 5% H 
TM-IEC C1galt1-/- 
WT 
Monoassociation 
by orogastric 
administration of 
pure culture or 
rubbing it in the 
mouse fur 
Sacrifice 20 or 30 days 
post-TM treatment. 
Collect blood, colon and 
cecum content    
Tamoxifen ip 
for five 
consecutive 
days 
 Day 1          3              8               15              20          25   28                         38 
Genotype Record mice 
weight every 
2-3 days 
Figure 4.1 Schematic representation of the experimental protocol.   Mice were genotyped for 
presence of the Cre gene to distinguish the TM-IEC C1galt1-/- from the WT, which were used as 
control. Mice were monocolonized through orogastric administration of 200µl of pure culture or by 
rubbing the culture onto the fur. Subsequently (48 to 72 hours post-colonization), 1mg of Tamoxifen 
(TM) diluted in an ethanol and sunflower oil mixture was injected intraperitoneally for five consecutive 
days to both, TM-IEC C1galt1-/- and WT.  Mice weights were recorded every 2-3 days.  Mice were 
sacrificed 20 or 30 days after TM treatment, depending on the bacterial treatment provided.  	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and 90% N2.  Bacteroides species included Bacteriodes thetaiotaomicron VPI 5482, 
Bacteroides vulgatus ATCC 8482, and Bacteroides sartorii A-C2-0.  All Bacteroides 
were grown in TYG (per liter: 10g Tryptone, 5g Yeast Extract, and 11 mM (2g) Glucose, 
supplemented with 8.2mM (1g) cysteine, 1ml hematin-histidine solution (12mg hematin 
dissolved in 10ml of 0.2M histidine pH8), 1mg vitamin K3, 1ml of 0.8% calcium 
chloride solution, 2.6µM (0.4mg) ferrous sulfate, 100ml of 1M KPO4, and 40ml of TYG 
salts solution (per liter: 2mM (0.5g) MgSO4 heptahydrate, 119mM (10g) NaHCO3, 
34.2mM (2g) NaCl)). 
Other species used included: Clostridium disporicum ATCC 43838, grown in 
Reinforced Clostridial Medium (prepared according to instructions); Clostridium 
symbiosum ATCC 14940, grown in Modified Meat Medium (per liter: 125g Cooked 
Meat Medium, 30.0g trypticase [BD 211921], 5.0g yeast extract, 28.7mM (5.0g) 
K2HPO4, 4.0ml 0.025% resazurin, 4mM (0.5g) cysteine, 10.0ml hemin solution [50.0mg 
hemin, 1.0ml 1N NaOH, 100ml distilled water], 0.2ml vitamin K1 solution [0.15ml 
vitamin K1, 30.0ml 95% ethanol]); Akkermansia muciniphila BAA-835, grown in Brain 
Heart Infusion Broth (prepared according to instructions); and Lactobacillus johnsonii, 
isolated from mice fecal pellets and identified by 16s rRNA sequencing using the 
universal primers 8F (5′-AGAGTTTGATCCTGGCTCAG-3′) and 1391R (5'-
GACGGGCGGTGWGTRCA-3'), and grown in Modified MRS (per liter: 55g MRS, 
29.2mM (10g) of maltose, and 28mM (5g) of fructose), and Bifidobacterium longum 
grown in Modified MRS with added cysteine (0.05% per volume).   
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Bacteroides-colonized mice were euthanized at 30 days, except for B. vulgatus-
colonized mice.  Mice colonized with B. vulgatus and other selected bacterial species 
were sacrificed at 20 days post-TM treatment. 
 
Table 4.2 Bacterial species selected for monoassociation experiments 
 
Bacteria	   Reason	  for	  selection	   Reference	  
Akkermansia muciniphila Mucus degrader, decreased in UC patients Vigsnaes et al, 2012 
Bacteroides sartorii Mouse specific strain not associated with colitis Control strain 
Bacteroides 
thetaiotaomicron Colitic in HLA-B27 transgenic rat model Hansen et al, 2012 
Bacteroides vulgatus Colitic in gnotobiotic IL-10
-/- and HLA-B27 
murine models 
Sydora et al, 2005 
Rath et al, 1999 
Bifidobacterium longum Being study for probiotic effect 
Bai et al, 2006 
Ortiz-Lucas et al, 2013 
Rodes et al, 2013 
Clostridium disporicum Species increased in colitic TM-IEC C1galt1
-/- 
mice Chapter 3 of this thesis 
Clostridium symbiosum Clostridium species not associated with colitis Control strain 
Lactobacillus johnsonii Genus increased in colitic TM-IEC C1galt1
-/- 
mice Chapter 3 of this thesis 
 
4.2.3 Sample collection 
Mice were anesthetized using Isofluorane and blood collected for 
immunoglobulin measurement.  Cecum contents were snap-frozen in liquid nitrogen. The 
distal colon was divided into three sections and preserved in liquid nitrogen, Carnoy’s 
fixative (60% methanol, 30% chloroform, 10% glacial acetic acid), or 10% formalin, 
respectively.  
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4.2.4 Immunohistochemical and Immunofluorescence staining of 
distal colon tissue 
Procedures for immunohistochemical and immunofluorescence staining, and for 
determination of histological scores were discussed in Chaper 2. Bacterial probes used 
for FISH analysis are listed in Table 4.3.  Parameters used for determination of 
inflammation scores are specified in Table 4.4. 
 
Table 4.3 Bacterial probes used for FISH analysis 
 
Probe Target Sequence 5’ conjugation 
EUB338 Universal bacterial probe 5’-GCT GCC TCC CGT AGG AGT-3’ Texas Red 
CFB286 
Chlorobi/ Fibrobacteres 
Bacteroidetes 
Superphylum 
5’-TCC TCT CAG AAC CCC TAC-3’ Alexa Fluor 488 
MUC1437 Akkermansia muciniphila 5’-CCT TGC GGT TGG CTT CAG AT -3’ Alexa Fluor 488 
NON338 Nonsense/non-specific probe (negative control) 5’- ACT CCT ACG GGA GGC AGC-3’ Texas Red 
GAM42a Gamma Proteobacter Phylum 5’- GCC TTC CCA CAT CGT TT-3’ Alexa Fluor 488 
 
 
Table 4.4 Scoring parameters for assessment of inflammation 
Parameter 
Score 
           0                     1                        2                        3 
Lamina Propria CD45+ cells per HPF 
(% WT) 
 
      ≤105%          106-125%         126-150%            ≥151% 
Epithelial Hyperplasia 
(% WT) 
 
      ≤105%          106-125%         126-150%            ≥151% 
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4.2.5 Immunoglobulin measurement by ELISAs and Data 
Analysis 
ELISA protocols were followed for measurement of IgA, IgM, IgG, and IgG 
isotypes IgG1, IgG2a, IgG2b, and IgG3 as described in Chapter 2.  Statistical analyses for 
immunoglobulins levels between genotypes and within genotypes among bacterial 
treatments were determined by unpaired t-test with Welch’s correction using GraphPad 
Prism 5.0 (GraphPad Software Inc., USA) statistical software. 
 
4.2.6 Quantification of bacterial species by Quantitative PCR 
Quantification of total bacteria was performed by quantitative PCR (qPCR) using 
the universal primers 8F and 1391R after DNA isolation from cecal contents of the mice.  
DNA was extracted as described in Chapter 3.  Each PCR reaction was done in 20µl total 
volume, and consisted of 10µl of 2x SYBR Green QPCR master mix (Brilliant III Ultra-
Fast SYBR® Green QPCR Master Mix, Agilent Technologies), 1µl of each primer 
(10µM concentration), 7µl of nuclease-free water, and 1µl of genomic DNA template.  
Amplification was performed using a Bio-Rad CFX96 Real Time System model C1000 
Thermal Cycler.  The amplification program consisted of an initial denaturing step of 3 
minutes at 95°C, followed by 40 cycles, each consisting of 5 seconds at 95°C 
(denaturing), 10 seconds at 60°C (annealing), and 10 seconds at 68°C (extension).  
Fluorescence was measured at each cycle during the 60°C annealing-extension step. 
Submitting the amplified products to dissociation analysis generated melting curves.  Ten 
–fold serial dilutions of DNA extracted from pure cultures of each bacterium tested were 
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used to generate standard curves for absolute quantification.  DNA for the standard 
curves was normalized at 50ng starting concentration per reaction. Standard curves were 
made by plotting the threshold cycle values obtained from DNA of the dilution series as a 
linear function of the base 10 logarithm of the number of bacteria. Analysis of results was 
done by converting the CT value obtained for each sample to ng/µl based on the standard 
curve.  The amount of ng/µl was converted to its equivalent number of copies (based on 
genome size), and transformed to genome equivalents per gram of cecal contents (based 
on the initial amount of cecal content used for DNA extraction).  The final numbers were 
subjected to unpaired t-test with Welch’s correction using GraphPad Prism 5.0 
(GraphPad Software Inc., USA) statistical software for determination of statistically 
significant differences between the genotypes. 
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4.3  Results 
The main objective of these experiments was to assess the effect of individual 
bacterial species in development of inflammation, in the presence of a breach in the 
mucus layer, through the comparison of monoassociated WT vs monoassociated TM-IEC 
C1galt1-/-.  However, our results will be addressed in a number of ways.  For both 
settings, the monoassociated WT (intact mucus layer) and the monoassociated TM-IEC 
C1galt1-/- (defective mucus layer), we used GF and conventionalized mice, as negative 
controls (no bacteria) and positive controls (complete microbiota), respectively.  The 
comparison of monoassociated against GF mice (monoassociated WT vs GF WT, and 
monoassociated TM-IEC C1galt1-/- vs GF TM-IEC C1galt1-/-) isolates the effect of the 
mutation in inflammation (which was addressed in chapter 3) in the absence of microbes, 
and it allows us to evaluate changes caused by an introduced bacterium in both, an intact 
and a defective mucus layer.   Meanwhile, comparison of monoassociated mice with 
conventionalized mice (monoassociated WT vs. Conv WT, and monoassociated TM-IEC 
C1galt1-/- vs. Conv TM-IEC C1galt1-/-) helps to evaluate how the effect of a single 
bacterium compares to that of a complete microbiota, which resembles with greater 
accuracy the scenario in human IBD.  Our general results will also be discussed in 
comparison to those obtained by Fu et al (2011) in a conventional setting.   
4.3.1 Assessment of bacterial colonization (monoassociation) 
FISH and qPCR with the 16S rRNA universal primers 8F and 1391R were used to 
assess bacterial colonization.  Evaluation of mucosal association and colonization of the 
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distal colon by FISH showed robust colonization by B. thetaiotaomicron, B.vulgatus and 
B. sartorii (Figure 4.2), moderate colonization by C. symbiosum and L. johnsonii, and 
weak colonization by A. muciniphila (Figure 4.3), for both WT and TM-IEC C1galt1-/-.  
Similarly, statistical analysis of quantitative PCR performed on cecal contents of the 
mice showed no statistical differences in the number of bacteria between the WT and 
TM-IEC C1galt1-/- mice, independently of bacterial association.  However, the degree of 
colonization of each bacterial species in the cecum differed relative to the distal colon, 
with L.johnsonii showing the strongest colonization, followed by A. muciniphila, 
Bacteroides spp. and C. symbiosum in decreasing order of abundance.  Specifically, 
colonization values obtained from qPCR- measured as genome equivalents per gram of 
cecal contents- ranged from 2x108 to 4x108 for L. johnsonii; from 2x108 to 3x108 for A. 
muciniphila; from 1x107 to 1.6x108 for the Bacteroides spp.; and from 9x107 to 2x108 for 
C. symbiosum.  Discrepancies in the degree of colonization revealed by FISH and the 
numbers obtained from qPCR could be related to differences in the microenvironment of 
the two anatomical sites (colon and cecum), as it has been shown that different microbial 
species segregate along the GI tract, locating themselves in that part of the tract which 
best suits their growth requirements (Reviewed by Walter and Ley, 2011).  In addition, 
inflammation along the GI tract may result in differential induction of antimicrobial 
peptides by epithelial cells along different parts of the tract, thus creating an heterogenous 
environment that might include distinct regions unsuitable for colonization by certain 
bacterial species but fit for others (Hildebrand et al, 2013). 
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Figure 4.2 Bacteroides species colonized the colon in the absence of core 1 O-glycans.  
FISH analysis revealed robust colonization by B. thetaiotaomicron, B. vulgatus and B. sartorii 
in both WT and TM-IEC C1galt1-/- mice.  Note reduced mucus layer in the TM-IEC C1galt1-/- 
mice - the black space between the microbiota (yellow-green) and the epithelial cells (blue).  
Circles to the right show an amplified view of the interface between the microbiota and the 
epithelia. 
	   120	  
     
  WT (20X)       TM-IEC C1galt1-/- (20x) 
L.
 jo
hn
so
ni
i 
A.
 m
uc
in
ip
hi
la
 
C.
 sy
m
bi
os
um
 
Figure 4.3 FISH analysis revealed moderate colonization by C. symbiosum and L. johnsonii, and 
weak colonization by A. muciniphila in both, WT and TM-IEC C1galt1-/- mice.  The amount of 
bacteria seen in the distal colon of C. symbiosum, L. johnsonii, and A. muciniphila-colonized mice was 
reduced relative to that seen in Bacteroides-colonized mice.  Interestingly, the amount of bacterium in 
the C. symbiosum - TM-IEC C1galt1-/- colonized mice seems to be greater than the WT counterpart.  
However, no statistically significant differences in total bacteria were found between the genotypes as 
measured by qPCR in cecal contents of the mice.  Discrepancies between the amount of bacteria 
determined by qPCR and FISH analysis could be attributed to differences in anatomical sites tested.  
Note reduced mucus layer in the TM-IEC C1galt1-/- mice – the black space between microbiota (red) 
and the epithelial cells (blue).  Circles to the right show an amplified view of the interface between the 
microbiota and the epithelia. 
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4.3.2 Assessment of mutation induction 
 Evaluation of mutation induction in the monoassociated TM-IEC C1galt1-/- mice 
was performed as discussed in Chapter 3 for the conventionalized and GF TM-IEC 
C1galt1-/- mice.  Tn antigen and Alcian Blue staining were performed to evaluate an 
increased presence of Tn antigen in the mutated mice, and to assess reduction in the 
ability of goblet cells to produce mucus, respectively.  Figure 4.4 shows increased 
amount of Tn antigen in the mutated mice relative to the WT.  Figures 4.5A and 4.5B 
prove decreased mucus production (lack of blue staining within the crypts) in the 
monoassociated TM-IEC C1galt1-/- mice.  
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Figure 4.4 Deletion of the C1GALT1 enzyme caused increased production of Tn antigen in the 
TM-IEC C1galt1-/- mice. Pictures show presence of Tn antigen (stained brown) in WT and TM-IEC 
C1galt1-/- mice monoassociated with B. thetaiotaomicron (left) and B. sartorii (middle). The Tn antigen 
is a glyco-aminoacidic determinant linked to serine or threonine residues by a glycosidic bond 
(GalNAc-O-Ser/Thr).  It is masked in normal cells by type O saccharides chain elongation; therefore, it 
is expressed in some abnormal or sick cells when such elongation does not occur.  Upon deletion of the 
C1GALT1 enzyme responsible for core 1 O-glycosilation of the mucus layer, the Tn antigen was 
detected in higher amounts in the TM-IEC C1galt1-/- mice relative to the WT mice (right).   	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Figure 4.5A Alcian Blue staining revealed good mutation induction in the 
TM-IEC C1galt1-/- mice colonized with Bacteroides species.  AB staining 
revealed an impaired mucus production by the goblet cells.  Note “empty” crypts 
(lack of blue stain) in the TM-IEC C1galt1-/- mice in all bacterial treatments. 
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Figure 4.5B Alcian Blue staining revealed good mutation induction in the 
TM-IEC C1galt1-/- mice colonized with Clostridium symbiosum, 
Akkermansia muciniphila and Lactobacillus johnsonii.  AB staining 
revealed an impaired mucus production by the goblet cells.  Note “empty” 
crypts (lack of blue stain) in the TM-IEC C1galt1-/- mice in all bacterial 
treatments. 
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4.3.3 Development of disease in the monoassociated TM-IEC C1galt1-/- 
mice relative to WT mice 
Development of colitis was monitored by the appearance of classic disease signs, 
such as weight loss, development of diarrhea and rectal prolapse.  No statistically 
significant changes were observed regarding weight fluctuations. A general assessment of 
average daily weight gain (ADG) between genotypes (TM-IEC C1galt1-/- vs WT) in 
monoassociated mice revealed that the general trend was a decrease in ADG in the TM-
IEC C1galt1-/- relative to the WT counterpart, except for monoassociations with A. 
muciniphila and L. johnsonii, were TM-IEC C1galt1-/- gained more weight (on average) 
than the WT.   
ADG comparisons between monoassociated and GF mice- in both, WT and TM-
IEC C1galt1-/- conditions- showed that mice monoassociated with Bacteroides species 
had a decreased ADG, while the ADG in mice monoassociated with C. symbiosum, A. 
muciniphila and L. johnsonii increased, relative to their corresponding GF TM-IEC 
C1galt1-/- controls.  Yet, all these differences were not statistically significant.  Average 
daily weight gain with standard deviations, and p-values per treatment group and per 
genotype are listed in Table 4.5.  Development of rectal prolapse was not observed in any 
of the monoassociated TM-IEC C1galt1-/- mice.  No major alterations in stool consistency 
were observed.   
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Table 4.5 Mice average daily weight gain (ADG) and standard deviations (SD) 
per treatment and per genotype 
 
Treatment ADG WT ± SD (g) ADG TM-IEC  
C1galt1-/- ± SD (g) 
P-value 
Germ-free 20d 0.14±0.07 0.12±0.03 0.4769 
Germ-free 30d 0.11±0.03 0.10±0.03 0.5993 
B. thetaiotaomicron 0.10±0.04 0.07±0.04 0.2474 
B. vulgatus 0.10±0.02 0.06±0.02 0.0554 
B. sartorii 0.08±0.06 0.06±0.02 0.6371 
C. symbiosum 0.20±0.00 0.17±0.02 N/A 
A. muciniphila 0.11±0.02 0.13±0.06 0.5528 
L. johnsonii 0.14±0.06 0.16±0.08 0.6850 
 
4.3.4 Determination of colitogenic bacterial species 
The parameters addressed for the determination of inflammation scores in the 
monoassociation experiments (and therefore, for identification of inflammation-inducing 
bacteria) were the same as the ones used for evaluation of inflammation in the GF TM-
IEC C1galt1-/- mice (Table 4.4).  Infiltration of LP CD45+ cells and epithelial hyperplasia, 
observed in TM-IEC C1galt1-/- monoassociated mice were compared to those obtained 
for TM-IEC C1galt1-/- mice in GF and conventionalized settings (negative and positive 
controls, respectively).  However, determination of statistical significance was done 
exclusively between genotypes (monoassociated WT vs monoassociated TM-IEC 
C1galt1-/- mice).    Determination of inflammation scores for monoassociations with 
Bifidobacterium longum were inconclusive, thus will be addressed in future works.   
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The CD45+ marker, present in all leukocytes, was used to evaluate immune cell 
infiltration in the tissue as an indicator of inflammation (Figure 4.6).  Quantification of 
CD45+ immune cells showed that monoassociation with B. vulgatus caused a stronger 
tissue permeation with immune cells in the monoassociated TM-IEC C1galt1-/- mice than 
in their monoassociated WT counterpart, with up to an average of 1.9-fold increase in the 
number of cells (all changes in CD45+ cells are expressed as fold-change over WT in 
Figure 4.7).  Unfortunately, we only had one B-vulgatus-monoassociated WT control 
mouse, which hindered the completion of a strong statistical analysis between genotypes 
for this bacterial treatment.  However, comparisons of the CD45+ absolute numbers 
obtained for B. vulgatus-monoassociated TM-IEC C1galt1-/- mice against GF and 
conventionalized mice (for both, WT and TM-IEC C1galt1-/- mice), and against the other 
monoassociated TM-IEC C1galt1-/- mice were not significant, independently of bacterial 
monoassociation.  The second highest fold change in CD45+ cells was observed in TM-
IEC C1galt1-/- mice colonized with B. thetaiotaomicron (an average if 1.8-fold increase, 
p=0.017), followed by the conventionalized TM-IEC C1galt1-/- mice (1.6-fold increase, 
p=0.046).  In addition, monoassociation of TM-IEC C1galt1-/- mice with L. johnsonii 
showed significant infiltration of CD45+ cells into the tissue (1.5-fold increase, p=0.019).  
Interestingly, the presence of C. symbiosum in the monoassociated TM-IEC C1galt1-/- 
mice caused a significant decrease in the number of CD45+ cells (average of -1.4 fold 
decrease, p=0.016) relative to the monoassociated WT counterpart, which resembles the 
trend seen in the TM-IEC C1galt1-/- GF mice.  No significant changes in CD45+ cells 
were found in mice associated with A. muciniphila and B. sartorii.  Appendix B includes 
absolute numbers of CD45+ cells per treatment and genotype. 
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Figure 4.6 CD45+ cells were used as an indicator of an active immune response in the 
TM-IEC C1galt1-/- mice.  Changes in number of CD45+ cells were estimated to evaluate 
the immune response caused by the bacteria in the case of a breach in the mucus layer, 
relative to bacterial association in an intact mucosal barrier. 
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The second parameter used for the determination of inflammation scores was 
epithelial hyperplasia (Figures 4.8A and 4.8B).  The conventionalized TM-IEC C1galt1-/- 
mice showed the highest degree of hyperplasia, with the TM-IEC C1galt1-/- mice having 
up to a 1.6-fold increase  (average fold increase of 1.44, p=0.0323) in the number of 
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Figure 4.7 Lack of core 1 O-glycans and single association of GF mice with Bacteroides 
vulgatus and Bacteroides thetaiotaomicron caused stronger immune responses, as measured 
by changes in infiltrated lamina propria CD45+ cells, than mice associated with a complete 
microbiota.  B. vulgatus and B. thetaiotaomicron caused a 1.9 and 1.8 fold-change increase, 
respectively, in the number of CD45+ cells in mice monoassociated with these bacteria. The 
observed changes were greater than those seen in the conventionalized mice that have a complete 
microbiota.  In contrast, monoassociation with C. symbiosum caused a 1 fold-decrease in these 
cells.  Bars represent fold change over WT; error bars represent standard deviations.  P-values 
were estimated for changes between genotypes (WT versus TM-IEC C1galt1-/-). 
	   129	  
epithelial cells.  Following, in decreasing order, monoassociation of TM-IEC C1galt1-/- 
mice with B. thetaiotaomicron and with B. vulgatus had an average of 1.3-fold increase 
in epithelial cells (p=0.0323 for B. thetaiotaomicron monoassociation).   Contrary to B. 
thetaiotaomicron and B. vulgatus, B. sartorii and A.muciniphila, also gram-negative 
bacteria, did not cause significant changes in terms of hyperplasia.  The mild degree of 
hyperplasia caused by monoassociation of TM-IEC C1galt1-/- mice with L. johnsonii was 
similar to that found in GF mice.  Interestingly, C. symbiosum, which caused a 
statistically significant decrease in the number of CD45+ cells in TM-IEC C1galt1-/- 
mice, also caused significant hyperplasia (average of 1.2-fold increase, p= 0.0154).  All 
changes in the number of epithelial cells are expressed as fold-change over WT in Figure 
4.9. 
 Inflammation scores were estimated by the sum of scores given for changes in the 
numbers of CD45+ and epithelial cells as previously established (Table 4.4).  The highest 
scores were obtained for the conventionalized TM-IEC C1galt1-/- mice (p<0.0001), 
followed by monoassociation of TM-IEC C1galt1-/- mice with B. thetaiotaomicron 
(p=0.0024) and B. vulgatus, relative to their WT counterparts (Figure 4.11).  In addition, 
the differences between genotypes of C. symbiosum-monoassociated TM-IEC C1galt1-/- 
mice reached statistical significance (p=0.0310).  However, the total scores are 
comparable to the scores obtained for the GF TM-IEC C1galt1-/- mice.  Similarly, the 
scores obtained for mice monoassociated with B. sartorii, A. muciniphila and L. johnsonii 
are equivalent or lower than the ones calculated for GF TM-IEC C1galt1-/- mice (Figure 
4.10).  
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Figure 4.8A Assessment of epithelial hyperplasia in WT and TM-IEC C1galt1-/- mice 
monocolonized with Bacteroides spp. Note differences in the appearance of the tissue 
between the genotypes (monoassociated WT vs monoassociated TM-IEC C1galt1-/-) 
caused by increases in volume as a consequence of increases in the number of epithelial 
cells. Note differences in tissue appearance between the B. thetaiotaomicron-
monocolonized TM-IEC C1galt1-/- mice (top) and the B. sartorii-monocolonized mice 
(bottom). Circles to the right show a closer view of the tissue. 
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Figure 4.8B Assessment of epithelial hyperplasia in mice monocolonized with C. 
symbiosum, A. muciniphila, and L. johnsonii. Note differences in the appearance of the 
tissue between the genotypes (monoassociated WT vs monoassociated TM-IEC C1galt1-/-) 
caused by increases in volume as a consequence of increases in the number of epithelial 
cells. Circles to the right show a closer view of the tissue. 
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Figure 4.9 Bacteroides thetaiotaomicron and Bacteroides vulgatus caused a higher 
degree of hyperplasia than monoassociations with Bacteroides sartorii or other 
bacterial species tested.   The TM-IEC C1galt1-/- conventionalized mice (with a complete 
microbiota) presented the highest degree of hyperplasia among all bacterial treatments.  
Monoassociation with B. thetaiotaomicron and B. vulgatus caused the highest degree of 
hyperplasia among the monoassociation experiments. Bars represent fold change over 
WT; error bars represent standard deviations. P-values were estimated for changes 
between genotypes (WT versus TM-IEC C1galt1-/-). 
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Figure 4.10 Intestinal symbionts Bacteroides thetaiotaomicron and Bacteroides 
vulgatus are capable of inducing colitis in the absence of core 1 O-glycans.  B. 
thetaiotaomicron and B. vulgatus caused the highest degree of inflammation (as 
measured by lamina propria CD45+ cells infiltration in the colonic tissue and 
epithelial hyperplasia)  among the monoassociation experiments.  Monoassociation 
with B. sartorii, A. muciniphila, C. symbiosum and L. johnsonii did not induce 
inflammation. Error bars represent standard deviations.  P-values were estimated for 
changes between genotypes (WT versus TM-IEC C1galt1-/-). 
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4.3.5 B cell responses in monoassociated TM-IEC C1galt1-/- mice 
Adaptive immunity responses were assessed by measurement of immunoglobulin 
levels by ELISA.   Immunoglobulin levels were compared between genotypes (WT vs 
TM-IEC C1galt1-/-), and within genotypes (GFWT vs monoassociated WT, and GF TM-
IEC C1galt1-/- vs monoassociated TM-IEC C1galt1-/-).  Immunoglobulin levels for B. 
thetaiotaomicron and B. sartorii were compared against the GF controls 30 days after 
TM treatment (GF30), while for other bacteria used in these experiments comparisons 
were against GF controls 20 days after TM treatment (GF20).  In addition, comparisons 
between GF20 and GF30 were performed in a similar fashion.  A higher number of 
statistically significant differences were found within genotypes rather than between 
them, especially for the TM-IEC C1galt1-/- mice (Figures 4.11-4.13 and Table 4.5).  
In both, GF and monoassociated settings, a breach in the mucus barrier induced 
increases in serum IgA production in the monoassociated TM-IEC C1galt1-/- mice 
relative to their monoassociated WT counterparts (Figure 4.11A) independently of the 
bacterial species tested.  These changes were not statistically significant when comparing 
monoassociated WT vs monoassociated TM-IEC C1galt1-/- for every bacterial treatment, 
or when comparing monoassociated TM-IEC C1galt1-/- mice with GF TM-IEC C1galt1-/- 
mice.  However, they were significant between the genotypes in the GF setting at both, 
20 days and 30 days (p=0.0040 and p=0.0222, respectively).  Additionally, changes in 
serum IgA reached significance when comparing B.thetaiotaomicron-monoassociated 
WT and C. symbiosum-monoassociated WT mice relative to the GF WT control.  B. 
thetatiotaomicron induced an increase in serum IgA (GF30WT 32.15 ± 1.531	   vs 
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B.thetaiotaomicron WT 43.47 ± 2.55, p=0.0067), while monoassociation with C. 
symbiosum caused a decrease in the immunoglobulin level (GF20WT 30.49 ± 1.48 vs C. 
symbiosum WT 24.46 ± 0.40, p= 0.0029). 
Similar to serum IgA, an impaired mucus barrier caused increases in secretory 
IgA (sIgA) in the mutated mice relative to the WT in both, GF and monoassociated 
scenarios (Figure 4.11B).  However, contrary to what was found for serum IgA, 
significant changes between genotypes were found for sIgA in TM-IEC C1galt1-/- 
monoassociated with C. symbiosum and with L. johnsonii, relative to their 
monoassociated-WT counterpart (C. symbiosum WT 188.90 ± 4.74 vs C. symbiosum TM-
IEC C1galt1-/- 240.90 ± 14.29, p=0.0409; L. johnsonii WT 171.60 ± 7.90 vs L. johnsonii 
TM-IEC C1galt1-/- 271.00 ± 21.68, p=0.0499, respectively).  The only significant 
changes within the TM-IEC C1galt1-/- mice occurred in mice monoassociated with C. 
symbiosum, and the GF30 mice relative to the GF20 control (GF TM-IEC C1galt1-/- 
175.70 ± 7.42 vs C. symbiosum TM-IEC C1galt1-/- 240.90 ± 14.29, p= 0.0155; vs GF30 
203.20 ± 7.704, p=0.0258). 
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Figure 4.11 Lack of core 1 O-glycans causes increases serum and secretory IgA independently 
of germ-free status or bacterial species used for monoassociaton.   [A] Graphic representation 
of serum IgA production (systemic response) induced by selected bacterial species.  [B] Graphic 
representation of secretory IgA production (localized response) induced by selected bacterial 
species.  [A and B] The combined effect of a breach in the mucus layer and presence of bacteria has 
a greater impact in systemic and localized IgA immune responses than bacterial monoassociation 
by itself. Lines above bars indicate significant differences between mice of different genotypes 
(WT vs TM-IEC C1galt1-/- mice), while letters above bars indicate significant differences between 
mice of the same genotype (GF TM-IEC C1galt1-/- mice vs monoassociated TM-IEC C1galt1-/- 
mice or GFWT vs monoassociated WT). Error bars represent SD. 
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No trends were found in IgG and IgM production.  The values are dependent on 
bacterial monoassociation.  While some bacteria caused increases in the levels of both 
immunoglobulins, others caused decreases.  Once more, most changes were found within 
genotypes (GFWT vs monoassociated WT, or GF TM-IEC C1galt1-/- vs monoassociated 
TM-IEC C1galt1-/-) rather than between genotypes (WT vs TM-IEC C1galt1-/-).  While 
the levels of serum IgA and sIgA increased over time in the GF setting, the opposite 
occured with IgM and IgG, were the level decreased with time.   
In the case of serum IgG (Figure 4.12A), significant changes occurred exclusively 
within the TM-IEC C1galt1-/- mice (GF TM-IEC C1galt1-/- vs monoassociated TM-IEC 
C1galt1-/-).  B. thetaiotaomicron caused an increase in IgG, while A. muciniphila and L. 
johnsonii induced decreases in its levels relative to the GF control (GF30 TM-IEC 
C1galt1-/- 978.5 ± 196.0	   vs B. thetaiotaomicron  TM-IEC C1galt1-/- 1685.00 ± 59.15, 
p=0.0261; GF20 TM-IEC C1galt1-/- 1273 ± 100.0 vs A. muciniphila  TM-IEC C1galt1-/- 
714.6 ± 114.7, p=0.0144; and vs L. johnsonii  TM-IEC C1galt1-/- 908.2 ± 42.88, 
p=0.0052).   
In the case of IgM (Figure 4.12B), no significant changes were found between 
genotypes.  All bacterial monoassociations caused decreases in both WT and TM-IEC 
C1galt1-/- relative to their GF counterparts.  The majority of statistically significant 
changes were found within the WT mice for monoassociations with A.muciniphila, C. 
symbiosum and L. johnsonii (GFWT 395.6 ± 57.09 vs A.muciniphila WT 176.3 ± 13.98, 
p=0.0033; vs C. symbiosum WT 183.6 ± 8.482, p=0.0043; and vs L. johnsonii WT 199.0 
± 15.31, p= 0.0068).  Changes within the TM-IEC C1galt1-/- mice occurred in the GF 
setting and in monoassociation with L. johnsonii (GF TM-IEC C1galt1-/- 395.6 ± 57.09 vs 
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GF30 TM-IEC C1galt1-/- 236.4 ± 42.73, p=0.0258; and vs L. johnsonii TM-IEC C1galt1-/- 
231.4 ± 6.62, p=0.0072). 
 
 	   
 
 
 
 In regards to the IgG subtypes, no significant changes were found for IgG1 within 
or between genotypes (Figure 4.13A).  Significant changes between genotypes were 
found in monoassociations with B. sartorii and B. thetaiotaomicron in the induction of 
IgG2a and IgG2b, respectively (Figures 4.15B-C) (B. sartorii WT 4.376 ± 0.4013 vs B. 
sartorii TM-IEC C1galt1-/- 2.508 ± 0.2316 p=0.0275; B. thetaiotaomicron WT 175.5 ± 
17.16 vs B. thetaiotaomicron TM-IEC C1galt1-/- 315.7 ± 44.25, p=0.0213, respectively).  
 IgG
 
Ge
rm
-fr
ee
 20
d
 
Ge
rm
-fr
ee
 30
d
 
B.
 th
eta
iot
ao
mi
cro
n
 
B.
 vu
lga
tus
 
B.
 sa
rto
rii
 
C.
 sy
mb
ios
um
 
A.
 m
uc
ini
ph
ila
 
L. 
joh
ns
on
ii
0.5
1
2
4 a: p=0.0261b: p=0.0144
c: p=0.0052
a
b
c
 Ig
G
 (m
g/
m
l)
IgM
 
Ge
rm
-fr
ee
 20
d
 
Ge
rm
-fr
ee
 30
d
 
B.
 th
eta
iot
ao
mi
cro
n
 
B.
vu
lga
tus
 
B.
 sa
rto
rii
 
C.
 sy
mb
ios
um
 
A.
 m
uc
ini
ph
ila
 
L. 
joh
ns
on
ii
128
256
512
a: p=0.0499
b: p=0.0043
c: p=0.0033
d: p=0.0068
e: p=0.0072
a
b c
d
WT
TM-IEC C1galt1-/-
e
 Ig
M
 (u
g/
m
l)
A B
MM Igs graphs for manuscript.pzf:Layout 4 - Sat Jun  8 17:47:51 2013
Figure 4.12 Changes in serum IgG and IgM were dependent on microbial association rather 
than lack of core 1 O-glycans.  No specifics trends were found for IgG and IgM production 
between the WT and the TM-IEC C1galt1-/- mice.  Bacterial association had a greater impact on the 
production of these immunoglobulins, as some bacteria caused the values to increase while other 
caused decreases, independently of presence or absence of core 1 O-glycans. Lines above bars 
indicate significant differences between mice of different genotypes (WT vs TM-IEC C1galt1-/- 
mice), while letters above bars indicate significant differences between mice of the same genotype 
(GF TM-IEC C1galt1-/- mice vs monoassociated TM-IEC C1galt1-/- mice or GFWT vs 
monoassociated WT). Error bars represent SD. 
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The levels of IgG2a, IgG2b and IgG3 were significant in the L. johnsonii monoassociated 
TM-IEC C1galt1-/- mice when compared to the GF TM-IEC C1galt1-/- control (Figures 
4.13B-D). Even though the trend for IgG2b was an increase in the mutated mice, the 
majority of significant changes in IgG2b were among the WT mice:  monoassociations 
with B. thetaioatomicron caused increased level of IgG2b, while C. symbiosum and 
Akkermansia muciniphila caused decreases in the Ig subtype relative to their 
corresponding WT controls (Figure 4.13C).  
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Figure 4.13 Deficiency of core 1 O-glycans caused increases in IgG2b in the TM-IEC C1galt1-/- 
mice independently of bacterial association.  No trends were observed in the induction of IgG 
subtypes except for [B] IgG2b, were the mutation induced increases independently of bacterial 
association.  Lines above bars indicate significant differences between mice of different genotypes (WT 
vs TM-IEC C1galt1-/- mice), while letters above bars indicate significant differences between mice of 
the same genotype (GF TM-IEC C1galt1-/- mice vs monoassociated TM-IEC C1galt1-/- mice or GFWT 
vs monoassociated WT). Error bars represent SD. 
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Table 4.6 Comparisons of immunoglobulin levels between germ-free and monoassociated  
WT and TM-IEC C1galt1-/- mice 
   
Values represent means and standard errors of means (Mean ±  SEM).  Asterisks (*) indicate 
significant p values. Pound sign (#) indicates comparison was made against GF 30 days control. 
GF: Germ-free; TX: Monoassociated; WT: Wild type; KO: TM-IEC C1galt1-/- mice 
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Table 4.6 Comparisons of immunoglobulin levels between germ-free and monoassociated  
WT and TM-IEC C1galt1-/- mice 
(continuation) 
Values represent means and standard errors of means (Mean ±  SEM).  Asterisks (*) indicate 
significant p values. Pound sign (#) indicates comparison was made against GF 30 days control. 
GF: Germ-free; TX: Monoassociated; WT: Wild type; KO: TM-IEC C1galt1-/- mice 
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4.4 Discussion 
4.4.1 Intestinal symbionts Bacteroides thetaiotaomicron and 
Bacteroides vulgatus initiate colitis in the absence of O-
glycans 
Bacteroides thetaiotaomicron has been shown to be involved in the pathogenesis 
of colitis in several murine models, such as HLA-B27 transgenic rats (Rath et al, 1996; 
Rath et al, 1999; Hansen et al, 2012), and the double KO IL10r2- and Tgfbr2- mouse 
model of IBD (Bloom et al, 2011).  Similarly, Bacteroides vulgatus was recognized as an 
inflammation inducer, as it caused disease in the HLA-B27 transgenic rat model of IBD 
(Rath et al, 1996; Rath et al, 1999).  In the TM-IEC C1galt1-/- mice, monoassociation 
with B. thetaiotaomicron caused inflammation that closely resembles that seen in 
conventionalized mice, while inflammation caused by B. vulgatus could be considered 
moderate, compared to the same control (conventionalized mice).   
Metabolic analyses of B. thetaiotaomicron have shown its immense capacity of 
adaptation to its surroundings by expressing genes for carbohydrate utilization depending 
on source availability (Sonnenburg et al, 2005; Bjursell et al, 2006).  Specifically, it is 
known that this bacterium has a cluster of genes involved in glycans utilization (Martens 
et al, 2009).  However, even B. thetaiotaomicron mutants lacking genes for colonization 
and fitness (chuR-), and for O-glycans utilization (5xECF-) were able to induce moderate 
inflammation (data not included).  Therefore, deficiency of O-glycans does not affect B. 
thetaiotaomicron colonization capacity; on the contrary, it seems to create a favorable 
environment for the bacterium to initiate colitis.  Lack of O-glycosylation could be key in 
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deciding the fate of commensals, which may either remain as symbionts, or turn into 
pathobionts.   
 
4.4.2 Host specificity of Bacteroides sartorii and Lactobacillus 
johnsonii could have a role in prevention of inflammation in 
the TM-IEC C1galt1-/- mice 
Contrary to B. thetaiotaomicron, the inflammation scores of B. sartorii-colonized 
and L. johnsonii- colonized TM-IEC C1galt1-/- mice are comparable to the scores seen in 
GF TM-IEC C1galt1-/- mice.  Experimental evidence shows that gut microbes have 
evolved into host-adapted lineages through long-term evolutionary processes, thus 
developing a specialized symbiotic relationship with their host (Oh et al, 2009; Frese et 
al, 2011).  Since both, B. sartorii and L. johnsonii strains used in these set of experiments 
were mice-specific, the low intensity of inflammation induced in the TM-IEC C1galt1-/- 
mice by these two strains suggests that strain-host evolution could play a role in reducing 
the pathogenic potential of different bacterial species in this mice model.   
 
4.4.3 Lactobacillus johnsonii increased as a consequence of 
inflammation, while Clostridium disporicum increases 
caused inflammation in the conventional TM-IEC C1galt1-/- 
mice 
The monoassociation experiments using the TM-IEC C1galt1-/- mice model 
represent a simplified scenario of the etiology of UC, as these do not account for possible 
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interactions between different bacterial symbionts of the GIT.  In a conventional setting, 
development of inflammation could harm some bacterial species more than others, thus 
freeing resources for the surviving species, and reducing competition for nutrients and 
niches between the members of the microbiota.  The effect of such interactions is 
removed in a GF setting since competition is eradicated and resources become fully 
available for the single bacterium introduced into the monoassociated mouse.  
The L. johnsonii strain used in the monoassociaton experiments was isolated from 
conventional colitic TM-IEC C1galt1-/- mice, in which it was found increased relative to 
conventional WT mice (discussed in Chapter 2).  However, the TM-IEC C1galt1-/- mice 
mono-colonized with this bacterium did not present inflammation (in fact, they had a 
lower inflammation score than the GF TM-IEC C1galt1-/- mice).  On the other hand, 
preliminary results for monoassociation experiments with C. disporicum, a species that 
was also found increased in the conventional colitic TM-IEC C1galt1-/- mice, showed that 
this organism caused certain degree of inflammation (preliminary data in Appendix C) in 
the monoassociated TM-IEC C1galt1-/- mice.  In both of these cases where bacterial 
species showed increases in the conventional colitic mice, the bacteria may benefit from 
the lack of competition and possibly also from products released as a result of 
inflammation. Nevertheless, their opposite behaviors in the monoassociated TM-IEC 
C1galt1-/- mice suggest that the increase in L. johnsonii is a consequence of inflammation, 
rather than a cause, while increases in C. disporicum represent a cause of inflammation, 
and not a consequence. 
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4.4.4 Akkermansia muciniphila and Clostridium symbiosum might 
have a role in modulating the immune response in the TM-
IEC C1galt1-/- mice for prevention of inflammation 
Non-colitogenic bacteria were identified for the TM-IEC C1galt1-/- mice model 
through these sets of experiments.  The specific factors that decide why a bacterium 
remains a symbiont or become a pathobiont are unknown.  Aside from the potential 
beneficial evolutionary changes implied by host-specificity, specific bacteria may have 
beneficial effects on the host’s health, through the prevention or amelioration of 
inflammation.  
L. johnsonii, C. symbiosum and A. muciniphila induced comparable degrees of 
inflammation in the monoassociated TM-IEC C1galt1-/- mice, with similar or even lower 
scores than the ones obtained for the GF TM-IEC C1galt1-/- mice.  Even though some 
Lactobacillus species, including L. johnsonii in specific diseases, have been categorized 
as “probiotics” for their role as beneficial commensals or as species with putative roles in 
disease prevention or amelioration (Chiva et al, 2002; Valladares et al, 2010; Lee and 
Kim, 2011) this is not the case for A. muciniphila or C. symbiosum.   
In humans, A. muciniphila, a mucolytic bacterium, is reduced in active UC and 
CD (Png et al, 2010; Vignaes et al, 2012).  This species is unable to colonize well by 
itself, since the bacterium relies on of symbiotic interactions with other commensals to be 
able to colonize the host (Png et al, 2010).   In monoassociated TM-IEC C1galt1-/- mice, 
A. muciniphila appeared to cause mild hyperplasia, a mild increase in the number of 
CD45+ cells, and increases in almost all the immunoglobulins tested; however, none of 
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these changes resulted statistically significant relative to the monoassociated WT 
counterpart.  Still, it is possible that these mild qualitative and quantitative changes are 
indicative of a role of A. muciniphila in immune control and as an antagonist of 
inflammation development, as there is evidence that the bacterium induces the expression 
of genes involved in regulation of immune responses and maintenance of gut homeostasis 
(Derrien et al, 2011), and has the ability to decrease endotoxemia (Everard et al, 2013).    
Given that A. muciniphila was found in low numbers in the colon of both, the WT 
and the TM-IEC C1galt1-/- mice, this raises the question of whether the low histological 
inflammation score obtained in monoassociation experiments with this species could be 
attributed to ineffective or transient colonization caused by lack of O-glycans in the 
mutated mice, or by lack of syntrophic relationships with other members of the 
microbiota.  However, even though A. muciniphila was not able to strongly colonize the 
distal colon, it was found in high counts in the mice’s cecum, which is the preferred niche 
for A. muciniphila in the GIT (Derrien et al, 2011).  Bi- or multi-association experiments 
in TM-IEC C1galt1-/- mice using other “non-inflammatory” bacterial species would help 
to determine if this bacterium is able to strongly colonize the colon and act as a 
“probiotic” with several “non-inflamamtory” bacterial species.   
Regarding Clostridium, selected Clostridial species have been found to prevent 
disease in several murine models of colitis and other human diseases (Zhang et al, 2009; 
Hudcovic et al, 2012).  However, C. symbiosum specifically, which belongs to the 
Clostridial Cluster XIVa, has not been linked to IBD.  Accordingly, we used it in our 
experiments as a control strain.  Contrary to C. disporicum (preliminary data in Appendix 
C), the effect of C. symbiosum on tissue inflammation was minimal.  Interestingly, 
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although it caused moderate hyperplasia, C symbiosum caused a considerable decrease in 
the number of infiltrated LP CD45+ cells, which is opposite to what was found for other 
bacterial strains used for monoassociations. In addition, the commensal significantly 
induced production of sIgA, which has a role in gut homeostasis and inflammation 
prevention (Peterson et al, 2007).  Both, decreased number of CD45+ cells and increased 
levels of sIgA, propose an anti-inflammatory role for C. symbiosum.  The low 
inflammation scores obtained for C. symbiosum-monoassociated mice suggest that the 
bacterium caused minimum insult to the GIT, if any, and the change in histological 
scoring observed may have been due to the mutation per se.  
 
4.4.5 B cells responses are species-dependent 
The main biological functions of immunoglobulin, produced by B cells as part of 
the adaptive immune response, are directed towards eradication of invading pathogens.  
These functions include (i) agglutination of viruses and bacteria (mostly by IgM), (ii) 
opsonization, (iii) antibody-dependent cellular toxicity (usually IgG), (iv) neutralization 
(mainly IgG and IgA), (v) protection of the mucosa (IgA), and (vi) complement 
activation via either the classical pathway (activated by antigen-antibody complexes, 
mainly IgM and IgG) or the alternative pathway (spontaneously activated on contact with 
pathogenic cells, mainly by IgG and IgA) (Murphy et al, 2008; Abbas et al, 2010).  In 
regards to IgG subtypes, IgG1 and IgG3 are active in opsonization, the process by which 
antibodies bind antigens and activate phagocytosis by macrophages, neutrophils or 
polymorphonuclear leukocytes; while IgG2a, IgG2b and IgG3 act in complement 
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activation, one of the defense mechanisms of the humoral immune system.  All these 
functions represent different ways by which the immune system eliminates intruding 
pathogens.   
No trends have been found for IgM levels in humans with UC (Philipsen et al, 
1995; Dorn et al, 2002).  However, humans with UC have large amounts of IgG - being 
IgG1 the predominat subtype (Kett et al, 1987; Philipsen et al, 1995; Ruthlein et al, 1992; 
Furrie et al, 2003), - and decreased levels of IgA (Philipsen et al, 1995; Brandtzaeg et al, 
2006).   
Similar to human UC, in our monoassociation experiments, no general trend was 
found in the induction of IgM by monoassociated bacteria: while some bacterial species 
caused increases in IgM levels in the TM-IEC C1galt1-/- mice, others caused decreases, 
relative to the monoassociated WT counterpart.  Likewise, the assessment of results 
obtained for IgG, including subtypes IgG1 and IgG3, revealed no specific trends 
regarding differences between the genotypes.  Interestingly, parallel to human UC, IgG1 
was the most abundant subtype in all cases.  IgG2b on the other hand, showed an increase 
in the TM-IEC C1galt1-/- mice in all bacterial monoassociations. Though, (concerning 
IgG2b values) the only case that reached statistical significance was the monoassociation 
with B. thetaiotaomicron (which also obtained the highest inflammation score among the 
monoassociation treatments). Such an increase does make sense, since one of the 
functions of IgG2 is complement activation, and dysregulation of the complement 
cascade has been implicated in the pathogenesis of several inflammatory disorders 
(Harrison, 2010).  Some fragments of the complement cascade (i.e. C3a, C4a and C5a) 
are inflammatory mediators; thus, this suggests that higher levels of Ig2 could correlate 
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with higher levels of inflammation.  Interestingly, when B. thetaiotaomicron and B 
sartorii - Bacteroides species with the highest and lowest inflammation scores, 
respectively- are compared in terms of production of IgG subtypes, the trends are 
opposites, suggesting a causal relationship between the immune response and disease 
development.   
 
4.4.6 Secretory IgA protected against development of disease by 
selected commensal bacteria in core 1 O-glycans deficient 
mice 
 B. thetaiotaomicron and B. vulgatus, previously reported as inflammation 
provocateurs in several mice models of colitis, also induced severe inflammation in the 
TM-IEC C1galt1-/- mice. On the contrary, the inflammation scores obtained for B. 
sartorii, C. symbiosum, A. muciniphila and L. johnsonii – monoassociated mice were 
comparable to those obtained for the GF counterparts; thus these species did not induce 
inflammation.   
Secretory IgA has been characterized as a mediator of gut homeostasis due to its 
capacity for immune exclusion and anti-inflammatory roles through inhibition of 
inflammatory intermediaries (i.e. TNFα) (Peterson et al, 2007; Reviewed by Brandtzaeg, 
2010).  No significant differences were found in the levels of sIgA induced by B. 
thetaiotaomicron and B. vulgatus in monoassociated TM-IEC C1galt1-/- mice relative to 
their monoassociated WT couterpart, while the levels of sIgA induced by B. sartorii, C. 
symbiosum, A.muciniphila and L johnsonni were increased in the mutated mice relative to 
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the WT control.  Indeed, results obtained for monoassociations with B. thetaiotaomicron 
and B. vulgatus resemble what has been found in human UC, were the levels of sIgA in 
IBD patients are lower than in controls (Philipsen et al, 1995; Brandtzaeg et al, 2006).  
Even though only the levels of sIgA in the C. symbiosum and L johnsonii-monoassociated 
mice reached statistical significance, results suggest a role of sIgA in prevention of 
inflammation in the TM-IEC C1galt1-/- mice.   
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5.1 General Conclusions 
 5.1.1 Disease phenotype is microbe-dependent 
We have identified both, potential protective and colitogenic bacteria in the TM-
IEC C1galt1-/- model of UC, which complement findings from other murine models of 
IBD, such as the IL-2-/- and the IL-10-/- mice (Balish and Warner, 2002; Waidmann et al, 
2003; Muller et al, 2008).   While monoassociations with B. thetaiotaomicron and B. 
vulgatus induced inflammation in monoassociated TM-IEC C1galt1-/- mice relative to the 
corresponding monoassociated WT mice, the effects of B. sartorii, C. symbiosum, A. 
muciniphila and L. johnsonii were mild, and some even appeared to decrease the changes 
seen in GF mice.  This variation is in parallel agreement with results by Frank et al 
(2011), who worked in human IBD patients examining the relationships between 
different IBD genotypes, phenotypes and gut microbial communities, and concluded that 
IBD phenotypes are associated with changes in the microbiota.  The capacity of different 
bacterial species to either induce or prevent inflammation could be attributed to intrinsic 
characteristics of each species.  The histological scoring and immunoglobulin values 
found for each tested bacterium suggest that the development and severity of the disease 
is microbe-dependent.   
There is some level of disagreement between previous reports and the results of 
this investigation in terms of the specific effect of some bacterial species on the 
inflammatory process.   For example, B. vulgatus was found to be colitogenic in the TM-
IEC C1galt1-/- mice, but protective in the IL2-/- mice model.  Discrepancies such as this 
could be attributed to the intrinsic characteristics of each bacterial strain, since strains of 
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the same species might behave differently, and intrinsic characteristics of each mice 
strain or animal model used, since the outcomes of experiments will be dependant on the 
genetic manipulation that the model has.  The effects of the different treatments, in this 
case the bacterial species selected for monoassociations, will be conditional to how they 
are affected by the absence or presence of the manipulated gene.  Additionally, the 
monoassociation approach, used for these experiments and by other authors in their 
studies, eliminates competition and other metabolic relationships between microbial 
symbionts (inherent to a specific pathogen free or conventional microbiota) whose 
products might interact in complex ways to predispose or to prevent development of 
inflammation.  Therefore, it is expected that the behavior of a single bacterium will be 
according to the surrounding environment.   
Other environmental factors might affect results. For example, the gut microbiota 
will be directly affected by the diet, specifically the diversity and availability of nutrient 
sources, since not all microbial species have the same nutritional requirements for growth 
and development.  Additionally, microbes present throughout the housing facility could 
enter the gut as food “contaminants”, thus creating new sources of competition, which 
might impact the microbiota’s composition.  Age is also a determinant factor in the 
composition of the microbial ecosystem, since it is known that the predominant taxon in 
the GIT of a newborn is different from that of an adult.  Finally, differences in 
experimental treatments are expected to have different effects on the composition of the 
microbiome.   
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5.1.2 Breaches in the epithelial barrier (mucus layer) predispose to 
development of inflammation even in the absence of microbes 
Even though comparisons between GF TM-IEC C1galt1-/- mice and 
conventionalized TM-IEC C1galt1-/- mice showed that GF mice did not develop 
inflammation, several factors suggest that inflammation could be evoked in the absence 
of microbes in the TM-IEC C1galt1-/- mice.  Firstly, the mice for these experiments were 
sacrificed 20 days after TM treatment.  At this time, GF TM-IEC C1galt1-/- mice 
developed mild hyperplasia but they had a decreased level of CD45+ cells relative to the 
GF WT mice, thus skewing results towards a low inflammation score.   Even though we 
performed experiments keeping GF mice up to 30 days post TM treatment, we were 
unable to complete the histological analysis for this experimental group.   Consequently, 
in the context of a known genetic mutation and the presence of an incomplete mucus 
layer, it is still unknown if a higher degree of hyperplasia and, accordingly, higher 
inflammation scores would have occurred by more prolonged exposure of the epithelia 
and mucosal immune cells to environmental factors.  
  Secondly, we found differences in B cell responses between GF TM-IEC C1galt1-
/- mice sacrificed 20 days after the onset of the monoassociation experiment (GF20) and 
those sacrificed at 30 days (GF30).  Specifically, there were higher levels of sIgA in the 
GF30 than in the GF20.  This suggests that there is an active, strong, on-going immune 
response that could be attributed to a defective mucus barrier and which could, 
eventually, contribute to disease development.   
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Lastly, we hypothesize that the TM-IEC C1galt1-/- mice genetic background can 
contribute to development of the disease as it has been proved that genetic background 
greatly influences development of disease in other animal models (Mahler and Leiter, 
2002; Buchler et al, 2012; Reingold et al, 2013).  The C1galt1-/- mice originally produced 
by Xia’s Laboratory (OMRF, Oklahoma) were originated from a 129/SvlmJ mouse and 
bred into a C57Bl/6J genetic background (Xia et al, 2004).  Even though the conventional 
TM-IEC C1galt1-/- mice used by Fu et al (2011) were generated in a C57Bl/6 congenic 
background, the mice used in our experiments were backcrossed additional generations 
into the C57Bl/6J mice.  While Fu’s mutated conventional mice spontaneously developed 
colitis, in our system we found a mild disease phenotype in both, the conventionalized 
and monoassociated mutant.  It is unknown if the germ-free TM-IEC C1galt1-/- mice 
derived in a pure 129/SvlmJ genetic background would develop inflammation giving that 
the disease phenotype was found severe in earlier generations of conventional TM-IEC 
C1galt1-/- that were closer to a 129/SvlmJ background rather than a C57Bl/6J genetic 
background (Fu et al, 2011). 
 
5.1.3 The TM-IEC C1galt1-/- mice model of UC confirms the 
multifactorial etiology of IBD 
 The circumstances that evoke and perpetuate IBD converge along three main 
themes: host’s genetic susceptibility, gut microbiota and specific environmental factors.  
The synergistic effect of these factors may induce a strong, persistent immunological 
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reaction whose final outcome is chronic inflammation in areas of the GIT.  Our findings 
confirm the multifactorial nature of the disease (Figure 5.1).   
Firstly, the genetic background of the mice used as an animal model for the study 
of the human disease affects both, the microbiota and immune responses, predisposing to 
disease development (Gulati et al, 2012; McKnite et al, 2012). As discussed in the 
previous section, inflammation was severe in the conventional TM-IEC C1galt1-/- mice 
strains that were closer to a 129/SvlmJ genetic background rather than a C57Bl/6J 
background, while it was mild in the conventionalized and monoassociated TM-IEC 
C1galt1-/- that was backcrossed multiple generations into a C57Bl/6J background.  In 
addition, genetic manipulations impact results.  While WT mice did not develop 
inflammation in the monoassociation experiments, monoassociated TM-IEC C1galt1-/- 
presented various signs of disease dependent on the introduced bacterial species.   
Secondly, absence of microbes prevented development of the disease, confirming 
the role of the microbiota in the pathological process (Dianda el al, 1997; Reviewed by 
Podolsky, 1997).  GF mice did not develop inflammation in several murine models of 
UC, including our TM-IEC C1galt1-/- system.  Indeed, while association with single 
bacterial species was capable of skewing towards development of inflammation, a 
complete microbiota (conventionalization of GF mice) was capable of inducing the 
highest degree of inflammation among the bacterial treatments.  However, we also found 
differences in the ability of our selected bacteria to cause disease in our mice model.  Our 
results shares similarities with work from Stepankova et al (2007), who found that an 
IBD model of SCID mice reconstituted with CD45RBhigh CD4+ T cells did not develop 
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inflammation if kept GF, and in which single and defined combinations of bacteria could 
act either as colitogenic or non-colitogenic in their mice model.   
A third source of evidence for the multifactorial nature of the etiology of the 
disease relates to environmental factors.  For example, even though the TM-IEC C1galt1-
/- mice used by Fu et al (2011) received exactly the same TM treatment as the TM-IEC 
C1galt1-/- mice used in our experiments, our mice presented a mild disease phenotype 
while Fu’s mice spontaneously developed colitis.  Aside from the differences in genetic 
background already addressed, these two sets of mice were also raised under different 
environmental conditions.  Mice used by Fu’s team were grown in cages (conventional 
setting) at the mice facility of the OMRF in Oklahoma, while the mice used for these 
experiments were bred and raised inside an isolator, under germ-free conditions at the 
Gnotobiotic Mice Facility in UNL.  Differences in environmental conditions have an 
impact on immune system development.  In addition, the diet that these two groups 
received was not the same, nor was it handled in a similar manner (food and water for the 
GF mice goes through a sterilization process).  Indeed, for humans and other animal 
models the environment has been recognized as a factor predisposing to inflammation 
and disease (Campbell et al, 2012; Smith et al, 2012) 
Finally, even though, in the monoassociation experiments, changes induced by 
each bacterium in the amount of adaptive immune cells (T or B cell phenotypes) were not 
evaluated, and measurement of inflammation markers by ELISAs (such as TNFα and IL 
6) was not possible (due to low levels in serum), we were able to observe active B cell 
responses characteristic of each bacterial species.  For example, high levels of sIgA 
(relative to the WT counterpart) were seen for potential protective bacteria, such as C. 
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symbiosum and L. johnsonii, while low levels were found for colitogenic bacteria, such as 
B. thetaiotaomicron. 
Summarizing, even though dissimilarities exist in the degree of inflammation 
found in the conventional (Fu et al, 2011), and the conventionalized and monoassociated 
TM-IEC C1galt1-/- mice, results from this study confirm the multifactorial etiology of 
IBD.  Findings suggest that, after its initiation by a breach in the epithelial barrier, the 
disease progresses through changes in the constitution of the microbiota, and it is 
perpetuated by the synergistic effect of these two factors in the immunological system.  
The similarities between the human disease and the results found in our mutant mice 
model - namely increases in Lactobacillus (Willing et al, 2010) and Clostridium 
(Milonaki et al, 2005) and decreases in Lachnospiraceae (Frank et al, 2007) - highlight 
the adequacy of the TM-IEC C1galt1-/- mouse model.  The control afforded by this model 
in terms of timing of the introduction of the host’s defect (a weakened intestinal mucosal 
layer), and in terms of the extent of microbial colonization of the GIT of germ-free mice 
(monoassociation vs. conventionalization) have been instrumental in the elucidation of 
the complex interplay of factors involved with provoking inflammation in the context of 
a failed mucus barrier.  
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Figure 5.1 Diagram illustrating the multifactorial etiology of IBD in the TM-IEC C1galt1-/- 
mice.  Genetic background, environment, immune response and the gut microbiota converge in the 
development of inflammation and IBD.   
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5.2  Perspectives and Future Directions 
  The GIT is the ecological niche of a complex microbial population constituted 
by over 1014 microorganisms, including mostly bacteria.   This microbial population 
increases in density and complexity along the GIT, and it changes from a mostly aerobic 
composition in the stomach into an anaerobic environment in the ileum and distal colon 
(Sartor 2008). The microbiota has various physiological functions, and it benefits the host 
through (i) nutrient degradation, (ii) vitamin production, (iii) production of bactericidal 
compounds against opportunistic bacteria, (iv) contribution to epithelial cell 
differentiation, and (v) involvement in immune system maturation.  Most importantly, in 
the context of the present investigation, this microbiota is also one of the components of 
the intestinal barrier, as it occupies niches that might otherwise be colonized by 
pathogens.  
The commensal microbiota seems to be the most important etiologic factor in the 
pathogenesis of IBD.  This statement is supported by experimental evidence including: (i) 
that antibiotics improve inflammation in IBD; (ii) that the disease is preferentially 
localized were the microbial density is at its maximum (terminal ileum and colon); (iii) 
that mutations in genes related to microbial recognition have been identified in IBD 
patients; (iv) that epithelial barrier dysfunction predisposes to disease in animal models; 
and (v), that disease can be prevented in animal models if they are kept germ-free 
(Reviewed by Guarner, 2005).  It is apparent that certain gut bacterial species can either 
behave as beneficial commensals or become pathogenic, in response to either genetic or 
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environmental cues. But in spite of all the evidence connecting the gut microbiota to 
inflammatory processes, the specific factors that determine whether a bacterium remains 
a beneficial symbiont, or becomes a pathobiont, remain unknown. 
The metabolic capacities inherent to each bacterium (for example, the ability of 
expressing genes depending on the type of nutrients available in the surrounding 
environment, and the capacity of producing bactericidal compounds to compete for niche 
establishment) may be considered “broad” or “limited” when compared to other members 
of the microbiota.   These metabolic capacities are what confer a bacterium the ability to 
colonize and persist in the GIT.  In the context of a defined genetic background, this 
raises the question of whether what may be seen as “ameliorating or protective effects” in 
a bacterium, may, in fact, represent the reduced pathogenic potential that results from a 
restricted ability to compete with other members of the microbiota, and with the host’s 
immune system.  This question is still unexplored and it is a prospective philosophical 
starting point to determine whether the metabolic capacities of individual bacterial 
species are key in either eliciting or preventing inflammation in the presence of an 
incomplete mucus layer.   Additionally,	   the	  monoassociation	  approach	  exclusively	  considers	   the	  effect	  of	  a	  single	  bacterium,	  eliminating	  the	  wide	  spectrum	  of	  possible	  interactions	  among	  competing	  members	  of	   the	  microbiota.	   	  The	  way	   in	  which	  one	  bacterium	  behaves	  during	  the	  process	  of	  colonization	  of	  a	  germ-­‐free	  host	  might	  differ	  significantly	  from	  its	   behavior	   in	   a	   more	   complex	   scenario,	   such	   as	   the	   conventional	   setting.	  	  	  Assessment	   of	   bacterial	   and	   host’s	   gene	   expression	   in	   mono-­‐,	   bi-­‐	   or	   multi-­‐association	  experiments	  would	  help	  in	  elucidating	  with	  more	  certainty	  whether	  or	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  not	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   bacteria	   elicit	   or	   prevent	   inflammation,	   and	   how	   they	   do	   so.	   	   A	   first	  order	  objective	  would	  be	  to	  determine	  if	  the	  “preventive/protective”	  behavior	  of	  a	  “non-­‐inducer”	   of	   inflammation	   would	   remain	   in	   the	   presence	   of	   other	   bacterial	  species,	   including	   both,	   inflammation	   “inducers”	   and	   “non-­‐inducers”.	   	   Similarly,	   it	  would	   be	   enlightening	   to	   assess	   whether	   the	   effect	   of	   a	   purported	   inflammation	  provocateur	  remains	  in	  the	  context	  of	  an	  increasingly	  complex	  gut	  microbiome.	  Furthermore,	  it	  is	  still	  unexplored	  how	  the	  identified	  “colitogenic”	  and	  “non-­‐colitogenic”	   bacteria	   impact	   the	   adaptive	   immune	   system	   in	   regards	   to	   T	   cell	  phenotypes.	   	   Studies	   have	   associated	   ulcerative	   colitis	   with	   a	   skew	   towards	   Th2	  cells,	  while	  in	  Crohn’s	  disease	  there	  is	  a	  skew	  toward	  Th1	  cells	  (Niessner	  and	  Volk,	  1995;	  Bhan	  et	  al,	  1999;	  Dong	  et	  al,	  2013).	  	  	  It is unclear if the “protective” effect of the 
bacteria is due to a state of tolerance towards the bacteria, to the intervention of 
regulatory T cells in maintaining homeostasis, or the bacterium exclusion by specific 
sIgA.  It is also unknown if the “colitogenicity” of the microorganism in the TM-IEC 
C1galt1-/- mice will skew towards Th2, thus resembling human UC. 
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5.3  Concluding remarks 
The complex pathogenesis of IBD warrants more research. Clearly, specific 
components of the microbiota play critical roles within the gut, either in prevention or 
development of inflammation.  Accordingly, alterations in the epithelial barrier and the 
mucus layer that in turn affect the microbiota could either be beneficial or detrimental to 
the host.  Furthermore, the intrinsic and extrinsic factors of the immune system determine 
the progression of inflammation. Advances in our understanding of mucosal immunology 
and of the composition, structure and metabolic profile of the gut microbiome will help 
elucidate the role of each player in the development of inflammation and of appropriate 
therapies.   
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Appendix A 
Fisher’s Z score 
 
Z = 
(p1 – p2) 
{ P(1 –P) 1              1 n1            n2 ( + ) } 
!
where P= 
p1n1  +   p2n2 
   n1   +   n2 
Under the null hypothesis that !1 = !2, Z is approximately 
distributed as a standard normal deviate. 
Objective 
To investigate the assumption that proportions !1 and !2 of 
elements from two populations are equal, based on two 
samples, one from each population.   
Methods 
It is assumed that the populations have proportions !1 and !2 
with the same characteristics.  Random samples of size n1 and 
n2 are taken and respective proportions p1 and p2 calculated.  
The test statistic is: 
Z test for the equality of two proportions 
Source: Kanji, Gopal K. (2006) 100 Statistical Tests.  SAGE 
Publications Ltd, London 3rd edition, p27   
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Appendix B 
CD45+ cells counts per treatment 
    
Each data point represents one high-power (40X) image 
Error Bars represent Standard Deviations 
Statistics represent the results of Unpaired t-tests 
 Germ-free   
B. vulgatus 
B. sartorii   A.muciniphila   
C. symbiosum   L. johnsonii   
  Conventionalized
   B. thetaiotaomicron   
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Appendix C 
Preliminary results for monoassociation with C. disporicum  
[A]  Histology: Monoassociation with Clostridium disporicum caused 
inflammation in the TM-IEC C1galt1-/- mice.  AB shows good mutation 
induction. 
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[B]  Comparisons of immunoglobulin levels between germ-free and 
monoassociated WT and TM-IEC C1galt1-/- mice 
 
Values represent means and standard errors of means (Mean ±  SEM).  Asterisks (*) indicate 
significant p values. GF: Germ-free; TX: Monoassociated; WT: Wild type; KO: TM-IEC C1galt1-/- 
mice 	  	  
[C]   Mice average daily weight gain (ADG) and standard deviations (SD) per 
treatment and per genotype 
 
Treatment ADG WT ± SD (g) ADG TM-IEC  
C1galt1-/- ± SD (g) 
P-value 
C. disporicum 0.13±0.02 0.07±0.03 0.0296* 	  
* Sex distribution could have affected p-values (3 out of 4 mice in the WT group and 2 out of 4 in the KO 
group were males) 
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